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ABSTRACT
The aim of this study was two-fold, (i) to examine variation in
the DNA of HSV isolates from patients presenting at the
Genitourinary Medicine Clinics and the Nuffield Transplant Unit,
Edinburgh, and (ii) to assess the reproducibility, specificity and
sensitivity of non-radiol abel 1ed nucleic acid hybridisation systems.
During the 19 month period 1.1.82 - 31.7.83 .,224 herpes
simplex viruses (180 HSV 2, 44 HSV 1) were isolated from new or
returned new patients presenting at the Department of Genitourinary
Medicine, the Royal Infirmary, Edinburgh. The non-radi ol abel1 ed DNA
from all isolates was purified by sodium iodide density gradient
centri fugation before being subjected to restriction endonuclease
digestion and separation by agarose gel electrophoresis. The
analysis was carried out with five restriction enzymes (EcoRI,
Bgl11, Hind 111, Kpn I, BamHI) for which published genomic maps are
avai1able.
Although the HSV 2 genome was found to be highly conserved, the
180 HSV 2 isolates could be divided into 18 groups on the basis of
deletions or additions of specific enzyme recognition sites. In
total 9 major variations were detected, three of which have not
previously been reported. These sites have been confirmed by nick-
translation and hybridisation with 32p_iabelled DNA probes. By
comparison all 44 HSV 1 isolates were distinguished purely on the
basis of major variations, 21 of which were recorded.
xi
The map positions of the major variations of HSV 1 and HSV 2
isolates were not found to correlate with the site of infection,
sex, or time of isolation.
The use of mobility variations as a means of determining
epidemiological relatedness was examined both on agarose and
pol yacryl amide gels using ethidium bromide and an ultrasensitive
silver stain respectively. Selected HSV DNA preparations were
examined to determine the extent of el ectrophoretic variation. These
included 35 concurrent HSV isolates from 17 patients, 14
sequential genital HSV isolates (from 7 patients), 54 HSV isolates
from known sexual consorts, 44 sequential oral HSV 1 isolates from
16 renal transplant recipients and 9 HSV 1 isolates involved in
possible hospital outbreaks.
Variations were observed mainly in the junction and terminal
fragments of the genome, however unique fragments, from both the
long and short segments, were observed to vary. These results
confirm that mobility variations should not be used as a means of
epidemiological distinction. Examination of 54 viruses from known
sexual consorts also highlighted the need for caution in the
i nterpretati on of RE results, particularly in the absence of
clinical and serological data.
Two non-radiolabel 1 ed detection systems involving biotin and
photobiotin were investigated with a view to establishing their
suitability in routine clinical procedures. Both systems were
compared for sensitivity and specificity, however several problems
encountered with the biotin labelled system prevented an accurate
xi i
assessment of its sensitivity. No such problems were encountered
with the photobiotin system, which proved reliable, specific and
sensitive enabling the detection of nanogram and picogram quantities




Until the discovery of the acquired immunodeficiency syndrome
(AIDS), herpes simplex virus (HSV) infection was perhaps the most
widely publicised sexually transmitted disease in the past decade.
Recent figures from the USA indicate that HSV still causes major
problems for the public health program, being responsible for an
excess of 500,000 new cases of genital herpes in 1985. The 'true
prevalence' of the virus however, is estimated to be much higher,
affecting approximately 20-60% of all Americans (ASM News^lOSG).
Historical Background
Herpes febrilis, the common cold sore, was first documented in
100 AD when the term 'herpes' was used to describe a variety of
spreading cutaneous lesions (Hutfield^1966). With time, clinical
and epidemiological features gave rise to the suggestion that a
different aetiologic agent was responsible for herpes febrilis and
herpes genitalis. Nevertheless, no virological distinction was
proven until the laboratory identification of two virus serotypes
(HSV 1 and HSV 2) by Schneweiss in 1962. Subsequent studies in 1967
(Dowdle et aj_., 1967; Schneweiss, 1967) correlated the antigenicity
of the virus with the anatomical site of isolation, thus giving rise
to the association of HSV 1 with herpetic infections above the waist
and HSV 2 with genital infections. Current figures now indicate
that over 20% of genital herpes is caused by HSV 1.
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Epidemiology and Incidence of Herpetic Infections
There has been widespread documentation of the prevalence of
HSV infections among various populations and age groups (Smith et
al1967; Nahmias and Roizman, 1973). In the adult population, a
high proportion of individuals have neutralising antibodies to HSV
1, particularly among lower socioeconomic groups. In newborn
children transplacental transfer of HSV antibodies may occur,
although the antibody levels tend to decline gradually over a 6-8
month period (Robertson et aj_., 1980). Antibodies to HSV 2 are not
usually detected until puberty and are correspondingly associated
with a history of sexual activity (Corey and Spear, 1986a).
Incidence of genital herpes in the UK and USA
Data on the incidence of genital HSV in the UK and USA (Fig 1)
have shown a marked increase in the rate of HSV infections. In the
USA the number of reported cases of genital HSV infections increased
dramatically during the years 1974-78. Although a small decline was
observed the following year (1979), the rapid increase of HSV
infection continued in 1980. Similarly in the UK, from 1971-78, a
marked increase in clinically apparent genital herpes was observed.
Prevalence of HSV infections in the UK
(i) England and Wales
Despite the fact that a 50% rise in the total number of HSV
isolations was recorded for the periods 1981-85 (Fig 2), the overall
increase was due to the rising incidence of genital herpes. In
3
Figure 1
The incidence of genital herpes simplex virus in the USA and UK
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1981, 6660 cases of genital HSV were reported by the laboratories,
whereas four years later the number of cases had risen to 15,316
(Source - Communicable Diseases Surveillance Centre).
(ii) Scotland
During the period 1980-85 the total number of cases of herpetic
infections investigated by laboratories in Scotland increased from
755 to 1452. Surprisingly, the years 1983-84 showed no apparent
rise in the number of genital isolates whereas in 1985 non-genital
HSV infections reported by the laboratories decreased by well over
100 cases to 539 (Source - Communicable Diseases (Scotland) Unit).
(i i i) Edinburgh
A marked increase in the incidence of genital HSV infections
was observed between 1980-82, but there may now be a downward trend
(Fig 2). By comparison the number of reported cases of non-genital
HSV infections have shown very little variation between 1980-85
(Source - University of Edinburgh).
The Pathogenesis of Herpetic Infections
The first infection with HSV may or may not produce clinically
apparent signs and symptoms of disease. Following the first
infection, antibodies appear and the virus, unable to be eliminated
from the body, enters a latent state. Periodically, reactivations
of the latent virus may occur giving rise to virus shedding, either
with or without the appearance of localised lesions.
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Although no uniform terminology exists to identify the various
types of infection, the following definitions are widely accepted:
(a) Primary Infections - infections occurring in individuals
without antibodies to the virus.
(b) Initial Infections - the first infection of an individual with
a heterologous virus serotype.
(c) Recurrent Infections - infections produced by reactivation of
the virus from a latent state.
In general any illness associated with recurrent or initial
infection tends to be milder than on primary exposure, due to the
presence of antibodies. In some immunosuppressed individuals
however, the illness associated with recurrent infection can be
severe and in extreme cases fatal , despite the presence of
antibodies. Individuals particularly at risk are the newborn, burns
patients and organ transplant recipients.
The Mechanisms of Latent Herpes Simplex Virus Infections
It is generally accepted that during the acute phase of
infection, herpes simplex virus is taken up by the nerve endings and
travels, probably as a non-infectious nucleo-capsid, towards the
neurones of sensory ganglia (Klein 1985). When the human host has
recovered from the primary infection, the virus becomes established
in a latent form in the neurons of the sensory ganglia and may be
reactivated by a number of trigger mechanisms (Docherty and Chopan
1974).
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As virus can be isolated from the saliva, tears, and genital
secretions of apparently asymptomatic individuals (Buddingh et al.,
1953; Kaufman et_ aj_., 1967; Jeansson and Molin, 1970), one
suggested mechanism of latency is that during a primary infection,
the virus may become established in the tissue (eg cervix, salivary
or lacrimal gland) close to the site of recurrence, then replicate
slowly, until the introduction of a stimulating factor (ie fever,
trauma, UV light) makes the area susceptible to localised
reinfection (Docherty and Chopan, 1974).
An alternative hypothesis maintains that the virus enters a
non-replicative (static) state between reactivations, and may
subsequently be activated to a replicative state with, or without,
the redevelopment of herpetic lesions (Docherty and Chopan, 1974).
In support of this theory is the isolation of HSV from cultures of
human ganglia (Baringer and Swoveland, 1973).
Recent findings suggest that the distinction between a 'static'
and a 'dynamic' state of latency is by no means clear-cut (Klein,
1985), indeed the processes are most probably not exclusive of one
another. However, regardless of the mechanisms of latency, the
frequency of reactivating events is determined mainly by the
immunological state of the host (Docherty and Chopan, 1974). A
notable example of this can be found in individuals with impaired
eel 1-mediated immunity such as organ transplant recipients, in whom
therapeutic immunosuppression is usually followed by the development
of recurrences.
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CLINICAL FEATURES OF HERPETIC INFECTIONS
The following sections provide a brief account of the main
clinical aspects for a variety of herpetic infections. The sections
dealing with the genitalia and infections in immunosuppressed
individuals are more extensive, as these topics are relevant to the
present study.
(i) Oral Infections
In young children, from 1-4 years old, HSV 1 is usual ly the
cause of a primary infection in the form of acute gingivostomatitis.
The clinical features include the presence of vesicles, which
rupture to form ulcers on the tongue, palate and buccal mucosa.
However, accompanying features such as fever, malaise, tenderness
and loss of appetite are also common. Identical clinical features
may be seen in young adults who, having escaped childhood infection,
acquire a primary infection from oral contact with someone who has
HSV (Robertson et ajL, 1980).
Herpes labialis is usually caused by recurrent HSV 1
infections. The characteristic lesions or "cold sores" develop on,
or near, the lips and are often preceded by a burning or tingling
sensation. Unlike gingivostomatitis, a high incidence of herpes




(a) A number of cases of traumatic herpes have been reported
in sportsmen who practise contact sports and in nail-biting
individuals. In such cases the skin lesions do not usually produce
scarring, however the recurrent nature of the infection may produce
a cosmetic problem for the individual (Ha 1 e j?t a_l_., 1963; Wheeler
and Cabaniss, 1965).
(b) Members of several professions including doctors, nurses
and dentists are particularly prone to the development of a painful
HSV infection of the finger known as herpetic whitlow. Inoculation
may occur by direct entry through minor abrasions, or by infection
from patients with primary or recurrent herpes (Wheeler and Cabaniss
1965). The onset is usually abrupt with swelling, redness and
tenderness at the site of infection.
The infection may either be primary or recurrent, dependent on
the presence or absence of antibodies in the infected individual.
In either case, the whitlow is usually resolved within two to three
weeks (Manzel 1 a et al_., 1984) in the absence of secondary bacterial
infection. Transmission of the virus may occur before healing and
has been known to cause outbreaks of gingivostomatitis in patients
attending infected dental personnel (Watkinson, 1982; Manzel 1 a et
aj_., 1984).
(c) Primary dermal herpes can be experienced both in children
and adults, resulting mainly in a few scattered lesions. In some
individuals, with complicated eczema, very extensive skin
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involvement may be seen in the form of eczema herpeticum, a variety
of Kaposi's varicel 1iform eruption (Feldman and Sonnabend, 1979).
(iii) Ocular Infections
The eyes are particularly vulnerable to p< ^<x^i nfecti on by
autoi nocul ati on"|f rom infected hands or saliva. In most cases
primary infections are rarely severe (Darougar _et a_l_., 1985).
However, recurrent infections usually result in acute keratitis that
may cause impairment of vision, or in extreme cases, blindness
(Kaufman, 1981).
(iv) HSV Encephalitis
' HSV infections of the central nervous system (CNS) (known to
occur in approximately one in every 500,000 Americans each year) are
usually the consequence of herpes encephalitis (Whitley, 1984).
Originally HSV encephalitis was thought to be a disease of the
elderly. However, figures now indicate that over one third of the
cases are found in young children and adolescents (Whitley et al.,
1981). In newborns 80% of the infections are caused by HSV 2,
whereas HSV 1 infections are more common in the older population
(97%) (Whitl ey, 1984).
The infection becomes localised in the temporal and orbito-
frontal areas of the brain, usually resulting in haemorrhagic
necrosis. Fever, autonomic nervous dysfunction, seizures and
fluctuating levels of consciousness are not uncommon features. In
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young chi1dren malaise, disorientation and i rritabi1ity may also
occur.
(v) Neonatal Infection
Neonatal HSV infection is often symptomatic, occurring either
as a disseminated, or localised disease, dependent on the extent of
involvement of the infected infant (Nahmias and Roizman, 1973).
Disseminated infections commence ten to twelve days after birth and
are combined with signs such as irritability, seizures, jaundice,
vesicular rashes and respiratory distress. Eighty per cent of all
cases have CNS involvement, although in the majority of cases death
is attributed to pulmonary disease (Whitley, 1984).
Both asymptomatic and mild localised infections of the CNS,
skin, eyes, or oral cavity can occur in 50% of infected infants
(Nahmias et aK, 197f).0 The CNS involvement is very similar to that
seen in disseminated infections, but the onset of illness is shorter
and the mortality rate lower. Nevertheless, survivors usually
experience residual brain damage (Whitley, 1984).
Skin infections, observed in 10% of infected newborns, are
commonly acquired from HSV 2 or HSV 1 genital lesions of the mother
(Feldman and Sonnabend, 1979). Recently however, van der Weil e_t
a 1 . (1985) have documented one case of paternal transmission from
herpes labial is. An accepted approach to the prevention of neonatal
HSV is to perform caesarian sections in pregnant women with known
active or recent genital infection near term. Difficulties arise at
the time of delivery when asymptomatic infections are encountered in
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mothers with no known history of herpetic infection (Whitley et al.,
1980). Other difficult decisions have to be made when pregnant
women, with a past history of infection or recent history of
contact, seek reassurance that normal delivery will not expose the
child to harm.
(vi) Infections of the Genital Tract
Genital herpes was first recorded by Astruc in 1736, an era
when French prostitution was under medical surveillance (Hutfield,
1966). At this time no particular name was given to the condition,
but Astruc recorded that it was a disease common to both men and
women. This idea was refuted in the 19th century when Greenough
suggested that the condition was unique to men, in particular those
with a history of venereal disease. A few years later Unna reported
the disease in 4.7-9.1% of prostitutes and stated that recurrences
often coincided with menstruation (Hutfield, 1966).
In the 20th century genital herpes has become one of the most
notorious sexually transmitted diseases. Changing attitudes towards
sexual behaviour in the 1960s caused an upsurge in the number of
genital HSV infections. In the 1980s, the incidence of the disease
is still thought to be increasing, although the problem has been
much exaggerated by the media. Scare-mongering allegations that HSV
could be contracted from inanimate objects such as toilet seats,
have now been dismissed by laboratory findings (Becker and Nahmias,
1985). However, many cases of anxiety and depression are still
encountered in infected individuals, due to the social stigma of the
recurrent disease.
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Until the 1970s HSV 2 was thought to be the cause of all
genital infections, with HSV 1 producing infections at sites above
the waist. Then in 1971 and 1973 results of studies in the USA
(Nahmi as jit a_l_., 1971) and UK (Smi th _et aj_., 1973) indicated that
between 3.4 and 16.9% of al 1 indi viduals with genital herpes were
infected with HSV 1. In 1977, Kal inyak et aj_. reported an extremely
high incidence (37%) of genital HSV 1 in a population of college
women, although current figures now suggest that 20-33% of all
genital HSV infections will be caused by HSV 1 ( McCaughtry et al.,
1982; Docherty _et a_l_., 1984). (The implications of these figures
are discussed in the next section - Orogenital Infections).
Rectal and perianal infections with either HSV 1 or HSV 2 are
being increasingly recognised in the form of HSV proctitis.
Although a large proportion of the cases are seen in homosexual men,
the condition is also prevalent in heterosexual women who engage in
ano-rectal intercourse (Corey and Spear, 1986b).
Epidemiological studies clearly indicate that a high proportion
of HSV infections are being transmitted from asymptomatic sexual
consorts (Mertz et al., 1985). Recent figures from the USA (Becker
and Nahmias, 1985) suggest that as many as 75-90% of patients who
demonstrated HSV 2 antibodies in their serum were unaware of having
experienced any clinical manifestations of herpes. Thus,
individuals with asymptomatic infections clearly present a high risk
to any sexual partner (Rooney et al., 1986).
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(a) Clinical manifestations
In males, multiple or grouped vesicles and ulcers may appear on
the glans, prepuce or shaft of the penis, although herpetic
urethritis and anorectal herpes are also common. In women, the main
site of involvement is the cervix, which is usually affected at a
subclinical level. Painful ulcerations of the vulva and vagina may
also occur with accompanying features such as adenopathy (Feldman
and Sonnabend, 1979).
Patients experiencing primary genital herpes frequently have
systemic manifestations ( eg gevNe.<oAv.s<eA howe v e r
individuals with initial or recurrent genital infections tend to
have a milder course of illness.
A history of itching, pain and/or sacral neuralgia 3-48 hours
prior to the appearance of lesions, is particularly important in the
diagnosis of recurrent disease. However, the frequency of
recurrences appears to differ among individuals and is known to be
influenced by the serotype of HSV with HSV 2 infections more prone
to recurrences than HSV 1 infections (Corey et aU, 1983).
(b) Prevention
At present, condoms are thought to provide an effective barrier
to virus transfer, although it is recognised that the only absolute
prevention is to avoid contact with lesions of an infected partner
(Feldman and Sonnabend , 1979). Difficulties arise when
asymptomatic infections occur and precautions are not taken, or when
partners are unaware of the risks of oro-genital transfer and other
mechanisms of direct or indirect transmission.
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(c) Association with carcinogenesis
The increased prevalence of genital herpes, coupled with an
increased incidence of cervical carcinoma in young women, prompted
many epidemiological and ser ological investigations to establish an
association between HSV and cervical cancer (Rawl s et_ a_l_., 1969;
Barton ejb aj_., 1982; Nahmias _et aj_., 1973). It is now recognised
that cervical cancer and infection with HSV 2 occurs more frequently
in women with multiple sex partners and who have first coitus at an
early age (Stravasky ert a_l_., 1983). Examinations of patients with
cervical neoplasia have demonstrated the presence of HSV proteins
(Aurel ian _et _al_., 1981) and viral RNA in cancer cells and tissues
(McDougal 1 et a!., 1980; Egl i n et aj_., 1981). HSV DNA has also been
reported in one cervical tumour (Frenkel et al_., 1971), although
subsequent studies have been unable to confirm this result (zur
Hausen et aj_., 1974; Pagano, 1975). A limited portion of the HSV
genome has, however, been demonstrated by in situ hybridisation of
cervical carcinoma sections (McDougal 1 et a_l_., 1980; Egl in et al ,
1981). In such cases the use of cloned, sub-genomic fragments of
HSV 2 DNA all owed the authors to define specific regions (0.7-0.8 A
0.85-0.87, 0.88-0.98 map units) of the HSV 2 genome that were
transcribed in 60% of cervical biopsies. In addition, McDougal 1 et
al. (1982) and Park et. aj_. (1983), have detected a further region
(0.58-0.63 map units), in 10-12.5% of cervical specimens, that may
be associated with the transformation process.
At present a specific role for HSV in the process of carcino¬
genesis has not been determined. Two possible mechanisms for
transformation have been suggested. One, the 'hit and run' theory,
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proposes a fortuitous involvement of HSV in carcinogenesis (M
S* "- ' >
q^Wow^y and McDougal 1 , 1983), whereas zur Hausen (1982) postulates that HSV '
may interact as a co-carcinogen with other agents (such as HPV),
known to infect the cervix. To date, no firm evidence in support of
either hypothesis is available (Cox et aj_., 1986; Grussendorf-Cohen
et al., 1986).
(vii) Oro-genital Infections
Recent surveys of the sexual practices in homosexual and
heterosexual populations report a high incidence of oro-genital
contact in the sexually active 15-24 year old age groups (Chacko et
a 1 ., 1982; Soendjojo, 1983). These findings have also been
substantiated by the large number of HSV 1 genital infections found
in American college students (male 26%, female 37%), with the most
likely transmission being by oro-genital contact (McCaughtry et al.,
1982; Docherty _et a_l_., 1984).
Despite the possibility that many oral HSV 2 infections may be
contracted during oro-genital relationships, very few cases of oral
HSV 2 isolations have been recorded (Kaufman and Rawls, 1972;
Nahmias and Roizman, 1973; Wolonitis and Jeansson, 1977; Schlesinger
et a 1 ., 1978; Tustin and Kaiser, 1979; Corey jet aj_., 1983). Indeed
the highest isolation rate was found in a select group of patients
known to be engaged in oro-genital sex with people who had a part
history of genital HSV 2 infections (Corey et_ aj_., 1983). In this
case 11% of patient with primary genital herpes had HSV 2 isolated
from the pharynx, however HSV isolations were also obtained from
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patients suffering from non-primary initial (1%) or recurrent (1%)
genital infections. Many of the patients had recently been
diagnosed as having streptococcal pharyngitis since the accompanying
symptoms included mild erythema, ulcerative pharyngitis, headaches,
fever and malaise.
A more recent attempt to determine the incidence of oral HSV 2
infections has been carried out by Docherty et aj_. (1985). In their
study of 69 students, 55 were found to have clinical symptoms of
oral infection. However, only 43 HSV samples were isolated and all
were typed as HSV 1. By interview it was determined that the
severity of HSV infection bore no relationship to the sexual
behaviour of the individuals concerned.
It has been suggested that the low recovery rate of oral HSV 2
may, in part, be due to the acquisition of HSV antibodies from a
prior infection in the oral region (Docherty et_ a_l_., 1985). Thus,
exposure to oral HSV 2 would not necessarily produce a primary
infection, and instead an asymptomatic or mild initial infection may
occur. o-cVse r 5T D s o vr Vsoeo.) isolation
from apparently asymptomatic individuals is common (Weisner et al.,
1973; Young and Bain, 1983).
(viii) Herpetic Infections in Renal Transplant Recipients
Viral infections associated with the herpesw^vxses are known
to cause major complications for organ transplant recipients
receiving immunosuppressive therapy (Pass et aj_., 1979; Dummer et
al., 1985; Locksley et al., 1985; Weirtheim et al., 1985). In many
18
cases HSV infections are severe and result in prolonged viral
shedding (Whitley, 1984) that usually occurs within 30 days of
transplantation (Wal ker et aU, 1982).
Serological data has confirmed that the majority of clinical
manifestations of HSV following renal transplantation are due to
reactivations of the latent virus (Warrel 1 et aj_., 1980). However,
it has been established, both for HSV and CMV infections, that the
kidney itself can be a source of viral infection (Berg!in et a 1.,
1982; Weirtheim et a_l_., 1983; Grundy et a_l_., 1986).
(a) Clinical manifestations
In immunosuppressed individuals HSV infections may extend into
the mucosal and deep cutaneous layers of the skin. Accompanying
features such as necrosis, bleeding and pain, coupled with the
inability to eat or drink, are frequently experienced (Naraqi et_
al., 1977; Passat aj_., 1979; Meyers e^t aj_., 1980). In the first
month following renal transplant, cold sores commonly occur but
subsequent infections tend to be less common and usually return to
the same frequency as that before transplantation.
(b) Immunosuppressive therapy
For many years azathioprine (a derivative of 6-mercaptopurine)
has been the standard method of long-term immunosuppression in most
transplant centres. The dose range of 2-5mg/kg is adjusted
according to the white cell count and renal function.
Corticosteroids such as prednisolone are also used as a major
immunosuppressive therapy because of their anti-inf1ammatory effect
and stabilisation of the lysosome membranes (Chi sholm, 1983).
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Despite previous debates about the optimum dosage of prednisolone,
most units now follow the 'Belfast regime1; a 1 ow-1 evel dose of
steroids in the early post-transplant period (McGeown et aj_., 1977).
Cyclosporin A (CsA), a fungal cyclic-peptide, is commonly used as an
alternative to azothioprine. Although it has been shown to be an
effective immunosuppressant several reports have expressed concern
regarding the long-term effect of CsA therapy and oncogenesis
(Sheil, 1984; Thompson _et aj_., 1985). Current recommendations
suggest that CsA treatment is safe when used only in patients who
have immediate function of their kidney grafts after transplant
(Chisholm, 1983).
GENOMIC ORGANISATION OF THE HERPESVIRIDAE
Classification of the Herpesviridae
The current classification of the members of the family
Herpesviridae is based both on biological properties and sequence
arrangement of the viral DNA (Table 1). This allows division of the
viruses into three subgroups, the alpha herpesy i ridae («*), the beta
herpesvi ridae (^) and the gamma herpesvi ridae (Y).
(a) Alpha herpesviridae (e.g. HSV, PRV)
Classification is based on a variable host range and short
reproductive cycle. In cell culture they produce a rapid cytopathic
effect and destruction of the infected cells. In animals, a latent
viral infection is frequently established, found mainly in the
ganglia.
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(b) Beta herpesviridae (e.g. CMV)
The members of this subgroup have a relatively narrow host
range and slow reproductive cycle. J_n v i t ro, the infection
progresses slowly, with cell enlargement being a frequent
occurrence, although a similar enlargement of the infected cells may
also be found j_n vivo. The viruses can be maintained in a latent
form in the kidneys, secretory glands, lymphoreticular cells and
other tissues.
(c) Gamma herpesviridae (e.g. EBV, HVS)
A characteristic of the members of this subgroup is the
extremely narrow host range, being limited to the family, or order,
of the natural host. In cell culture, replication occurs mainly in
lymphoblastoid eel 1 s.
*
Genomic Arrangements of the Herpesviridae
The DNAs of the herpes viruses differ in size, base composition
and structural organisation; however, all members of the herpes
family can be represented by one of five arrangements, as shown in
Fig 3.
The genomic structures of the five human herpes viruses (VZV,
CMV, EBV, HSV 1 and HSV 2) are complex arrangements of unique DNA
sequences and repeated regions. In HSV and CMV, the genomes (Type
E) are found in four isomeric forms; however, the DNA molecules of
VZV possess only one set of inverted repeats, bracketing the S
segment (Type D). In this case inversion of the S segment produces
only two isomeric forms. The DNA of EBV is completely different
22
Figure 3
A schematic diagram of the five types of genomes found in the family
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The horizontal lines represent unique sequences and the numbers
below represent millions of molecular weight.
*- reiterated sequences (excluding terminal reiterations). The
direction indicates the orientation (t direct, 4 indirect) of
the sequence.
Where more than one set of large repeats has been reported they
are designated as lower case Tetters, e.g. b and c reiterated
sequences in HSV DNA).
v.- terminal sequences. (All terminal reiterations are direct
repeats). Numbers below refer to the molecular weight of a
unit length of the genome.
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from the other human herpesjv i ruses and is categorised in genome
type C, which are found in only one isomeric form.
The DNAs of equine abortion virus (EAV) and pseudorabies virus
(PRV) possess a similar genomic structure to that of VZV (Genome
type D), despite the fact they originate in non-primate mammals.
Another mammalian herpes virus bovine man|illit*s virus (BMV) has a
DNA structure very similar to that of HSV (Genome type E),
particularly in the reiterated sequences of the terminal regions
(Buchman et_ 1979). Herpesvirus samiri (HSV) and herpesvirus
ateles (HVA) DNA have substantially different genomic structures
from the other herpesviruses (Genome type B). Although the channel
catfish virus (CCV) shares a similar structure, having only one
isomeric form, differences in the size and G + C base composition of
the genome are apparent (Genome type A). HVS and HVA genomes are
much larger consisting of a lengthy unique sequence, bracketed by a
number of tandem!y reiterated G + C rich sequences.
Structural Organisation of the HSV Genome
The genomes of HSV 1 and HSV 2 are linear, double-stranded
molecules of DNA (96 x 10^ molecular weight (mwt)), having a base
composition of 67 and 69% G + C respectively. The DNA structure
(Fig 4) consists of two covalently linked components, designated the
long (L) and the short (S) segments, that are composed primarily of
unique sequences (U|_ and Us)* The ^ on9 segment is bracketed by 9Kb
inverted repeats (a_ j) and J)V) and the short segment by 6Kb
inverted repeats (a'c1 and c a), that differ in base composition
24
Figure 4
The genome arrangement of HSV DNA.
Ul
82%
Ul - long unique region
U5 - short unique region
ab, b'a' - Ul reiterated sequences
ac, c'a' - U$ reiterated sequences
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from the inverted repeats of the long segment (Hayward et aj_., 1975a
and b; Wadsworth et_ aJL, 1975). A number of tandemly repeated
sequences (designated as the a^ sequence) are located at the termini
of the long and short segments (Grafstrom et aj_., 1975; Wadsworth et
al1975). Thus, the 'idealised' sequence arrangement for HSV DNA
i s i-Limb. - U]_ - bVn_c' - Us - jL.iS> where the underlined letters
represent inverted repeats, and the subscripts m is 0>10, and n is
1>10 (Roizman and Batterson, 1985). Alterations in the number or
size of the a_ sequence may result in inter- or intra-strain
variability (Roizman and Tognon, 1983; Hayward j?t aj_., 1984; Roizman
and Batterson, 1985).
(a) Isomeric Arrangements of HSV DNA
In 1975 Sheldrick and Berthelot suggested that the L and S
components could invert relative to each other. Subsequently it was
proven that DNA extracted from wild-type virions actually contained
an equimolar mixture of four isomeric forms, produced by the
combination of backward or forward orientations of the L and S
Cx.
f
segments (Fig 5) (Hayward et_ a_l_., 1975,; Wadsworth _et aj_., 1975;
Delius and Clements, 1976).
The four isomeric forms were designated as; prototype (P);
inversion of the S component (Is^» inversion of the L component
U[_); anc! inversion of both S and L components (I $L) (Roizman et_
al ., 1974; Hayward et aj_., 1975a and b). As a consequence of the L
and S inversions, cleavage by restriction enzymes, that cut only in




The isomeric arrangements of HSV DNA.
^ = cleavage site
Fragments from the termini are generated once in two isomeric forms
(e.g. a from the Long segment is generated once in P and once in 1$)
therefore are present 1/2 = 0.5M amounts relative to the intact DNA).
Fragments obtained from the joint segments (e.g. b + d, or a + d)
are generated once in four isomeric forms, therefore are present 1/4
= 0.25M amounts relative to the intact DNA.
Fragments from the Unique sequences occur in all four isomers, thus
are present in 4/4 = 1M amounts relative to the intact DNA (e.g. e
or f).
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(i) Four terminal fragments (a,c,b,d) each present in 0.5M
concentrations, relative to the molarity of the intact
DNA.
(ii) Four fragments from the 'joint' region, spanning the L
and S components (b+d, b+c, a+d, a+c), each present in
0.25M concentrations, relative to the molarity of the
intact DNA.
(iii) A number of fragments situated between the terminal and
junction fragments; each present in 1M concentrations
relative to the intact DNA (Hayward et a!., 1975-).
Although the number of fragments varies depending on RE
cleavage sites, the profiles obtained by electrophoresis on agarose
gels consists of a complex mixture of molar, half molar and quarter
molar fragments (Fig 6). Each fragment differs accordingly in
intensity when the gel is stained with ethidium bromide. Exceptions
occur when multicut restriction enzymes are used. For example, the
restriction enzyme Hpal cuts both in the unique sequences and the
inverted repeats as shown in Fig 7. Since the four genome
arrangements are present in equal amounts the cleavage produces:
(i) Five, 1 molar fragments (i, e, g, h, f) generated from
the unique regions and the end repeats cut by Hpal.
(ii) four, 0.5M fragments two of which (c and d) are
generated from the ends containing the uncut repeats.
The remaining two (h+c and h+d) are generated from areas
between the cleavage sites in the internal repeats and
the unique sequence in 11$. The short unique region has
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Figure 6
Submolar fragments displayed in the restriction enzyme cleavage








Schematic representation of the molar ratios of fragments in HSV 1
produced by cleavage with Hpal.
UJs
h I i i i h + d i f +
iLus
Us
I restriction enzyme cleavage site.
1M fragments: i, e, g, h, f
0.5M fragments: c, d, h + d, h + c
No 0.25M fragments.
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no cleavage sites in its flanking repeats. Thus,
inversions of the unique region containing the cut
flanking repeats, have no effect on the molar ratios of
the fragments produced in the long region. Since a
similar effect is produced by the fragments flanking the
short unique region, no 0.25M fragments are generated.
(b) Variability of the Restriction Endonuclease Profiles of
HSV DNA
Comparison of the RE profiles of HSV DNA with the relevant
standard strain(ie HSV 1 (17syn+) or HSV 2 (HG52)) reveals two
classes of variation: (i) presence or absence of RE cleavage sites,
and (ii) mobility variations mainly due to variations in the number
of tandemly repeated sequences.
The first type of variability gives rise to a change in
fragment number and molecular weight. Presence of an additional RE
cleavage sites results in the disappearance of a fragment and the
appearance of two new fragments. The sum of the molecular weights
of both new fragments is equivalent to that of the missing fragment.
Absence of a particular RE cleavage site results in the
disappearance of two (or more) adjacent fragments and the appearance
of a larger fusion fragment. The combined molecular weights of the
missing bands, which are always contiguous in the physical maps, are
equivalent to the molecular weight of the fusion
fragment (Fig 8). The second type of variability results in the
alteration of fragment molecular weight by more than ten per cent
(Buchman et al., 1980). This is mainly due to reduction or
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The 'spliced' gel photograph in this figure has been taken from a
single agarose gel. This condition also applies to all other
'spliced' photographs in subsequent figures.
amplification of the £ sequences (Hayward £t a_l_., 1975a and b;
Wagner and Summers, 1978; Locker and Frenkel , 1979).(_^<ie
It is well documented that alterations in the a_ sequences
results in inter- and intra-strain mobility variations (Hayward jrt
al1975t>,'Wagner and Summers, 1978; Locker and Frenkel , 1979;
Roizman and Tognon, 1982; Roizman and Batterson, 1985). However,
variability in the electrophoretic migration of non-terminal
fragments has al so been recorded. Locker and Frenkel (1979)
described minor size heterogeneities in the Ul segment of three USA
standard strains (HSV 1 (F), (Justin) and (VR-3)) when digested with
BamH I, KpnI and Sal I enzymes. Analysis of plaque-purified HSV 1
stocks has also revealed non-terminal fragment variations (Roizman
and Tognon, 1982). In this case although the variable fragments
mapped near the termini, the variability was thought to be
unrel ated to the a_ sequences. Further plaque purification of
variants showing rapidly or slowly migrating fragments allowed the
subsequent analysis of individual plaque-picked virus stock. In
each stock^alterations in fragment mobility were observed to vary
from fast to slow migration and vice versa.
Variations in the unique sequences of clinical isolates (both
HSV 1 and HSV 2) have al so been documented by Chaney et aj_. (1983a
and b). The HSV 1 genome showed variations in both the short (e.g.
Bamz) and the long (eg EcoRl) unique regions. By comparison the HSV
2 genome exhibited only two regions of variability (Bamy and Bg 1 i)
both in the long unique segment. Variations in the short unique
region were observed in subterminal fragments.
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A Comparison of HSV 1 and HSV 2 Genomes
The structure and sequence arrangements of the HSV 1 and HSV 2
genomes are very closely related (Kieff et aj_., 1971; Kieff et al.,
1972) having almost complete equivalence in the location of
homologous sequences and functions throughout the L region. In
addition the positions of the Us/U|_ junctions are reported to be
tightly conserved between the two genomes (Hayward ejt a_l_., 1984).
However, detailed differences have been observed and are as
follows:-
(i) The S unique region exhibits a three kilobase size
increase in HSV 2 compared with HSV 1 (Hayward et al
1984).
(ii) The nucleotide sequences of the terminally redundant a_
sequences have been shown to differ between HSV 1 and
HSV 2 (Davison and Wilkie^ 1981).
(iii) The glycoprotein C region is known to encode a 130K
glycoprotein in HSV 1, but a serologically poor cross-
reacting 75K glycoprotein in HSV 2.
( yy) Initially glycoprotein gG was thought to be found in HSV
2 and not HSV 1, however Richman et^ a_l_. (1986) have
recently reported a corresponding gG in HSV 1.
(v) Approximately 30% of the nucleotide sequences of the
thymidine kinease genes differ for HSV 1 and HSV 2
(Hayward et al., 1984).
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Inter-relationships of the Herpesviridae
Molecular hybridisation experiments have provided additional
evidence of an association between particular herpesviruses. The
DNA from some members of the al phaviridae (HSV, BMV, EAV, PRV and
VZV) have been found to have equivalence in the L segment near the
origin of replication and the region specifying the DNA-binding
protein (Hayward _et a_l_., 1984). The HSV 1 and HSV 2 genomes share
approximately 50% of their sequences (Ki eff et_ a_l_., 1972); the
regions of least homology occurring mainly in the S segment and the
inverted repeats of the L segment (TR|_/IR|_) (Wi 1 kie ejt aj_., 1979).
PRV DNA has shown 8-10% homology with HSV 1 and HSV 2 DNA (Davison
and Wilkie}1983) whereas EAV and VZV DNA is known to contain
homologous sequences to those of the HSV (1 and 2) genomes.
THE APPLICATION OF RESTRICTION ENDONUCLEASE ANALYSIS
IN EPIDEMIOLOGICAL STUDIES
The introduction of polypeptide analysis in 1974 (Heine et al.,
1974) demonstrated the usefulness ofmolecular technology in the
investigation of intratypic variations. Two years later Pereira et_
al. (1976) used a similar technique to examine the variations in 53
HSV 1 isolates. In this instance heterogeneity in the electro-
phoretic mobilities of seven structural polypeptides permitted
subdivision of the isolates into specific groups. Indeed the
identification of paired isolates by this method provided the first
molecular tool for epidemiological tracing. Parallel studies
(Hayward _et a_l_., 1975a) on the nucleotide sequence of HSV DNA
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introduced a superior technique for identifying isolate uniqueness
(Lonsdale _et aj_., 1979). Since that time restriction endonuclease
studies have provided invaluable information about the epidemiology
and genetic variability of HSV. The following sections provide a
brief account of the applications of RE analysis in epidemiological
studies and are summarised in Table 2.
(a) Transmission of HSV
In several studies (Buchman et_ a_l_., 1978; Linneman et al.,
1978; Hal peri n et aK, 1980) the variability in RE profiles has been
used to trace the spread of virus from one individual to another.
Much of the early work involved the study of HSV 1 infections in
paediatric intensive care units (PICU). Buchman _et aj_. (1978)
investigated an outbreak of HSV infection in patients, nurses, one
spouse and a dental pathologist. By analysis of the RE profiles and
the clinical information it was established that a single HSV 1
strain was not responsible for all the infections in the outbreak.
Instead, two independent introductions of HSV 1 had occurred; one
from a patient and the other from an asymptomatic nurse.
In the same year, Linneman _et a_l_. (1978) used RE analysis to
examine HSV 1 isolated from two infants in a newborn nursery. No
differentiation could be made between the isolates in this instance
therefore it was suggested that person-to-person transmission had
occurred.
Subsequent studies using RE analysis to trace nosocomial
transmission have followed a very similar pattern, either proving or
disproving transmission in a small number of individuals (Buchman et
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al., 1979; Hal perin et aj_., 1980; Buchman ejt aj_., 1980; Hammerburg
jrt aj_., 1983; Sakaoka j?t a_l_., 1984).
Evidence of adult transmission has also been investigated by RE
analysis. In 1985 van der Weil £t aj_. illustrated the need for
caution when a family member suffers herpes labialis. In this
instance a disseminated HSV 1 infection in a newborn infant was
acquired from the mother who had been infected by her husband during
a recurrence of herpes labialis. Caution is also required by dental
personnel prone to herpetic whitlows. Manzel 1 a jet a_l_. (1984) have
reported the transmission of HSV 1 stomatitis from dental hygienists
to patients.
More recently Davis et a_l_. (1985) and Rooney et aj_. (1986) have
examined the transmission of HSV 2 between sexual partners. Davis
ejt aj_. used RE analysis to confirm that an identical HSV 2 strain
was isolated from supposed sexual partners, and Rooney et al .
demonstrated the transmission of HSV 2 from an asymptomatic sexual
partner.
(b) Evidence of concurrent or concommitant HSV infections
Concomitant and concurrent HSV infections have also been
investigated by RE analysis. Embil et al_. (1981) showed that
concurrent penile and oral lesions from a single patient had been
caused by the same HSV 1 strain, whereas Fife et al. (1983) reported
two cases of concomitant genital infection with both HSV 1 and HSV
2. The RE data and clinical information led the authors to suggest
that either a concurrent, or successive infection with HSV 1 and HSV
2 had occurred. Subsequently both serotypes had become latent in
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one or more ganglia, and on reactivation had caused concomitant
genital infection. Similarly Whitley _et a_l_. (1982) studied
concomitant brain and oro-labial HSV isolates from eight patients
who had HSV encephalitis. Paired isolates from five patients were
found to be identical , with one of the five having had a primary
infection. This was therefore direct evidence that HSV encephalitis
could follow either a primary, or recurrent infection. The
discovery of non-identica1 HSV isolates in three patients
demonstrated that patients could be infected by two different virus
strains in the brain and oro-labial sites. Subsequent studies by
Dix et al. (1983) and McFarl ane ejt a_l_. (1985) have confirmed the
isolation of concomitant HSV 1 from brain and oro-labial sites,
where Gerdes et_ a_l_. (1981) have reported a case of concurrent HSV 1
infections in two brain sites.
(c) Evidence of reinfection with HSV
Restriction endonuclease analysis of genital HSV 2 infections
(Buchman et aj_., 1979) has provided unambiguous evidence of multiple
infections in patients with recurrent genital lesions. Serial
isolations of non-identical HSV 2 strains from one of the eight
patients examined, led the authors to suggest that individuals
previously infected with HSV 2 could be re-infected at the same or
nearby site.
A similar account of reinfection with HSV 2 has also been
provided by Maitland et £]_. (1982). In this study a non-identical
HSV 2 strain was recovered from one of thirty patients with
recurrent genital herpes. The frequency of reinfection with new HSV
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strains was investigated by Schmidt et_ a_l_. (1984) who studied 45
patients with symptomatic recurrent genital herpes. However, in
this case all symptomatic recurrences were found to be caused by
reactivation of the latent virus and not by reinfection with a new
HSV strain.
A novel account of reinfection was documented in 1983 by Kit et
al. During the first symptomatic episode of genital herpes, HSV 1
was isolated from the lesions of a single patient. However,
subsequent isolations from three successive episodes (recurring
four, seven and nine months after the HSV 1 infection) were found to
be caused by identical strains of HSV 2. Serological analyses
suggested that the patient had been exposed to HSV 2 prior to the
HSV 1 genital infection, therefore the authors concluded that HSV 2
infections are more likely to recur than their HSV 1 counterparts.
Reinfection and concurrent infection in the ganglion has also
been investigated by RE analysis. Lewis j?t aj_. (1984) reported the
recovery of non-identical strains of latent HSV 1 within the
trigeminal nerve complex of two individuals. In this instance, no
distinction could be made between exogenous reinfection or
concurrent infection with more than one strain of HSV because
clinical information was lacking.
(d) Strain variations within the population
The majority of epidemiological studies examining the RE
variations of HSV within a population have concentrated on small
numbers of patients (Table 2), although multiple HSV isolates from
individual patients have been examined. A comparative analysis of
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Table 2




(a) Transmission of HSV
(i) Neonatal
Buchman et al. 1978 12
Linneman et al. i» 4
Buchman et al. 1979 8
Hal pern et aT. 1980 4
Buchman et aT. " 2
Adams et al. 1981 4
Hammerburg et al. 1983 4
van der WeiT"et al . 1985 3
Sakaoka et al. 1984 6
(ii) Stomatitis
Manzella et al. 1984 6
(iii) Sexual
Mertz et al. 1985 20
Davis et al. ii 6
Rooney et al. 1986 3
(b) Concomitant/concurrent HSV infection
Embil et al. 1981 1
Gerdes et al . • i
Whit!ey et al. 1982 1
Fife et aT. 1983 2
Dix et al. <1 1
McFaTTane et al. 1985 2
(c) Reinfection with HSV
Buchman et al. 1979 (HSV 2) 8
Maitland et al. 1982 (HSV 2) 30
Kit et al. 1983 1






(d) Strain variability of HSV
Buchman et al. 1978 (HSV 2) 8
Lonsdale et~al. 1979 17
Brown 1980
Maitland et al. 1982 (HSV 2) 30
Sheppard et al. i< (HSV 2) 9
Barton et~Tl. in (HSV 1 + 2) 25
Chaney et aT. 1983a (HSV 1) 29
(HSV 2) 38
Chaney et al. 1983b 84
Sakaoka et al. 1985 93
Sakaoka et al. 1986 125
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genital HSV 2 isolates from 38 patients was carried out in 1983 by
Chaney j?t aj_. (a). In this instance the isolates were collected
from two geographically distinct areas in Canada. Also included in
the study were 12 genital and 17 facial HSV 1 isolates from each of
the two locations in Canada. On the basis of RE analysis, no
significant correlation between site of isolation and type of RE
variation could be detected. However, major RE variations could
distinguish all the HSV 1 isolates from each other; the HSV 2
isolates showed very little evidence of strain variability. A
subsequent paper by Chaney et_ aj_. (1983b) extended the study of HSV
1 isolates to include 55 ganglion, brain and facial isolates
obtained from the USA and Japan. Comparison of these isolates with
the HSV 1 isolates from Canada, revealed a significant difference in
the distribution of RE cleavage sites from each geographical
location and different anatomical site .
The variations in HSV 1 strains from three different
geographical locations in Japan have recently been investigated by
Sakaoka et_ a_l_. (1985). In this instance no significant differences
in the distribution of RE variations were noted in isolates from
patients living in close proximity (the areas of Torrori and
Kawanga). Yet isolates from Sapporo, a geographically distinct
area, showed a significant difference in the proportion of HSV 1
subtypes. Subsequent studies (Sakaoka et 1986) compared these
results with 32 HSV 1 isolates from Kenya, and again the
distribution of RE cleavage sites was found to differ significantly
between the two countries.
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Only one large scale study of HSV 2 variation has been
attempted from 30 patients attending a single clinical centre
(Maitl and et aK, 1982). In this investigation 65 multiple genital
HSV 2 isolates were examined by RE analysis, allowing the
examination of in vivo variation within an individual. Using
multicut enzymes (BamHI and SstI) considerable variability was
observed between paired isolates from the same individual. Fragment
variations observed for BamHI were assigned to the terminal or
subterminal regions but no assignation could be made for the SstI
results as no endonuclease map was available for consultation.
Nevertheless, the results indicated that specific variation could be
induced in the individual, despite the highly conserved nature of
the HSV 2 genome.
Epidemiological Tracing of Herpesviruses Other Than HSV
The variability of RE cleavage sites has also been used for
epidemiological tracing of other herpes virus infections; the
following sections provide an outline but are not an extensive
account for each virus.
(a) Human herpesvirus
Huang _et a_l_. (1980) have provided a detailed analysis of both
in vitro and i_n vivo variations in CMV, a virus with a similar
genomic arrangement to that of HSV. Analysis of plaque-purified
standard CMV strains (AD169 and Towne) demonstrated that
modifications of minor fragments could occur. Variations j_n vivo
were analysed by the examination of four case studies, as outlined
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in Table 3. In each case RE analysis demonstrated that j_n vivo
rearrangements may have occurred which resulted in minor differences
in the RE cleavage sites.
Additional epidemiological information with respect to the
horizontal transmission of CMV has also been provided by neontal
transmission (Huang j5t aj_., 1980; Spector, 1983; Hutto and Pass,
1984; Adler et aj_., 1985), neonatal -adul t transmission (Spector and
Spector, 1982; Dworsky _et aJL, 1984) and sexual transmission
(Hansfield et aU, 1985). The transmission of CMV from donor organs
to the recipient has also been investigated by RE analysis
(Weirtheim et a_l_., 1983; Grundy £t aj_., 1986). Similar genomic
differences have been used for epidemiological tracing in both VZV
(Pinchini et^a_l_., 1983; Strauss e_taj_., 1983; Embil e^ta_l_., 1986)
and EBV (Dambaugh et a_l_., 1980) isolates.
(b) Non-human herpesvirus
RE analysis has also provided a useful tool for the
differentiation and classification of non-human herpesviruses.
Osorio j?t a_l_. (1985) used a combination of RE analysis and
serological data to define five major types of bovine herpes virus
from the USA; infectious bovine rhinotracheitis virus (BHV 1),
bovine herpes mammillitis virus (BHV 2), malignant catarrhal fever
virus (MCF), bovine CMV-like virus and Pennsylvania 47 group virus.
In the same way Sabine et al. (1981) and Studdert et al. (1981) have
(Cewl)
classified two groups of equine herpes virusesjwith respect to their
RE cleavage profiles. More extensive RE analysis of foetal and
respiratory EHVli sol ates (Allen ejt a_l_., 1983a) confirmed the
existence of two EHV subtypes and the apparent lack of heterogeneity
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Table 3
Examples of the applications of RE analysis in the study of CMV
infections
Subject Author
(i) Recurrent maternal infections




















Sexual Transmission Handsfield et al. 1986





among EHV 1 isolates. In a subsequent study (Allen et_ aj_., 1983b)
the authors also examined the alterations of EHV 1 isolates after
serial passage in non-equine cell lines. The alterations, as
determined by multicut enzymes, were thought to be due to sequence
additions or deletions resulting in electrophoretic mobility
variations of both terminal and unique fragments. Comparable work
on the stability (Menglingjat aj_., 1983; Wathen and Pirtle, 1984)
and epidemiological differentiation (Paul jit aj_., 1982; Pirtle jit
al., 1984) of PRV strains has also been made possible by means of RE
analysis.
THE DEVELOPMENT OF NON-RADIQLABELLED PROBES
FOR THE DETECTION OF NUCLEIC ACID SEQUENCES
In recent years DNA hybridisation probes have provided an
invaluable tool for use in the investigation of a wide variety of
conditions, including infectious disease, cancer, and genetic
abnormalities. Originally the probes were prepared by labelling a
specific DNA sequence with a radioisotope (such as 32p)s which could
then be hybridised to target DNA and detected by autoradiography.
However, limitations associated with the use of radioisotopes in
routine diagnostic procedures have prompted the development of non-
radiolabel 1 ed DNA detection systems.
The potential use of non-radiolabel 1 ed nucleic acid probes was
first realised by Miller et_ a_l_ (1966) who observed that the
carcinogen N-acetoxy-2-acetyl-aminof1uorene (AFF) could bind to low
levels of nucleic acids in rat liver. Some AFF was metabolised by
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the rat to N-hydroxy-AFF which could be bound in vitro to high
c
concentrations of nucleic acids by modification of the guanosine
residues.
These modifications have more recently been further adapted to
provide immunodetectable probes for in situ and blot hybridisations
(Landegent _et a_K, 1984; Tchen _et aj_., 1984). Tchen _et aj_. (1984)
modified the nucleic acids (Fig 9) by means of an vitro enzymi c
reaction with N-acetoxy-N-2AAF and its 7-iododeri vati ve (AAIF) to
make the nucleic acid immunogenic. The immunogenic nucleic acid
probe could then be hybridised to immobilised target DNA and
detected by an AAF-modified guanosine antibody and fluorescent-
labelled second antibody. Similarly, Landegent et a_l_. (1984) used
comparable AAF-nucleic acid probes for the examination of
microscopic preparations of mouse satellite and human CMV DNA. Both
methods allowed single and double-stranded nucleic acids to be
labelled and could easily detect complementary nucleic acid
sequences. However, the use of AAF, a known carcinogen, made the
procedure unsuitable for routine diagnostic application.
Many alternative methods employed for the production of non-
radiolabel 1 ed probes involve labelling the nucleic acids with the
vitamin, biotin (see Fig 10). In 1975 Manning e^t a_l_. developed a
method of el ectrostatically cross-1inking biotin-1abel 1 ed cytochrome
C (a positively charged protein) to nucleic acid by treatment with
formaldehyde but this procedure proved to be unsuitable since the
probes were unstable under hybridisation conditions. Renz (1983)
overcame this problem by covalently cross-linking biotin-1 abel 1ed
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Figure 9
Preparation and detection of immunonucleic probes (adapted from













histone H 1 (a lysine-rich DNA-binding protein) to single-stranded
nucleic acids in the presence of g1utara 1dehyde. After
hybridisation, the target DNA was detected with an avidin-peroxidase
conjugate; however, the detection appeared to be much less
sensitive than procedures that exploited radioisotopes. Renz and
Kurtz (1984) then avoided the use of avidin/biotin systems by cross-
linking either peroxidase or alkaline phosphatase to a small (1.5Kb)
synthetic polymer, polyethyleneimine. This method of electrostatic
cross-linkage allowed simultaneous hybridisation with two DNA probes
by use of two colorimetrical1y detectable enzymes (peroxidase and
alkaline phosphatase) as the protein moiety of the probe.
Complementary DNA sequences for each probe were visualised by
development in two separate substrate solutions, thus al lowing a
colorimetric differentiation specific for the different probes.
An al ternative method of preparing non-radiolabel 1 ed probes was
developed by Langer _et aj_. (1981), who incorporated biotin into DNA
by the process of nick translation using biotinylated derivatives of
uridine (UTP) and deoxyuridine triphosphate (dUTP). In this
instance hybridisation signals could be detected by the appropriate
immunof1uorescent (eg antibody) or affinity (eg avidin) reagents.
Two years later, Leary et_ a_l_. (1983) reported an enzymic detection
protocol for use in the visualisation of biotinylated UTP DNA probes
(Fig 11). After nick translation and hybridisation the residual
probe is removed by washing procedures before the nitrocellulose
filters (containing immobilised nucleic acid) are incubated with an
avidin or streptavidin (SA) complex and biotinylated polymers of
intestinal alkaline phosphatase (B-polyAP). The nucleic acid
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Figure 11
Visualisation of target nucleic acid sequences as described by Leary














sequences can then be visualised by incubation with a mixture of 5-
bromo-4-chl oro-3-indolyl-phosphate (BCIP) and nitroblue tetrazolium
(NBT) dyes, resulting in a blue/purple colour development at the
sites of hybridisation.
Recently Forster _et aj_. (1985) have developed a novel method
for labelling DNA with a photo-activable analogue of biotin; N-(4-
azido-2-nitrophenyl)-N1 -(N-d-biotinyl-3-aminopropyl)-N'methyl-1,3-
propanediamine), more commonly called photobiotin (Fig 12).
Brief irradiation of photobiotin with visible light forms
stable linkages with single or double-stranded nucleic acids,
yielding a nucleic acid probe. Following normal hybridisation
conditions target DNA can be detected by colorimetric development
with biotinylated avidin-al kaline phosphatase conjugates as outlined
by Leary et £l_. (1983).
A number of 'ready-to-use' kits are currently available for the
detection and identification of specific nucleic acid sequences.
These commercially prepared products include reagents for
biotinylating DNA, detection kits, in situ hybridisation kits and in
some cases, specific biotinylated probes (eg HSV, EBV, chlamydia).
Reports from the manufacturers indicate that non-radiolabel 1 ed probe
technology has been successfully applied to dot-blot analysis,
colony hybridisation, in situ and Southern blot hybridisation.
Investigations into the sensitivity and reproducibility of the
results are currently being done in by other laboratories (McKeating
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et aj_., 1985), and results indicate the need for caution in the use




The aim of this study was two-fold:
(i) To examine variation in the DNA of HSV isolates from patients
presenting at the Genitourinary Medicine Clinics and the
Nuffield Transplant Unit, Edinburgh.
•! :* '
) To assess the reproducibi 1 ity, specificity and sensitivity^#









Cell Culture and Media
(i) Human embryo fibroblasts (HEF) prepared in the Department of
Bacteriology and a continuous line of Vero cells were grown in
Eagle's minimal essential medium (MEM) (Crui ckshank et_ aj_., 1975)
supplemented with 5% (v/v) heat-inactivated newborn calf serum
(NBCS) obtained from Flow Ltd.
(ii) Bacterial host LE3952 obtained from the Department of
Genetics, was grown in NZCYM medium (Maniatis et jil_., 1982).
Standard Reference Strains
(i) Viral strains 17syn+ (HSV 1) and HG52 (HSV 2) were kindly
supplied by the Institute of Virology, University of Glasgow.
(ii) Adenovirus 2 stock was obtained from Dr N Maitland (formerly)
Department of Genetics, University of Edinburgh.
(iii) Bacteriophage X (Charon 4A) was kindly supplied by J
Kinross, Department of Genetics, University of Edinburgh.
Cloned DNA
(i) Cloned HSV DNA (EcoRI-0) and vector pBR322 were supplied by
Dr N Maitland, University of Edinburgh.
(ii) Cloned HPV DNA (2 and 4) were kindly provided by Dr S
Burnett, University of Birmingham.
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(iii) Cloned HBV DNA (8-1-37) was a gift from Professor K Murray,
University of Edinburgh.
(iv) Cloned CMV DNA (Hindl11-1) was supplied by the PHLS
Laboratory, Porton Down.
Patients
(i) 371 clinical isolates of genital HSV infections were obtained
from 302 patients attending either the Department of Genito-urinary
Medicine (GUM) of the Royal Infirmary, Edinburgh, or the South Fife
Hospitals. The clinical details of these patients were provided by
Dr G Scott (GUM).
(ii) Twenty seven oral HSV samples from renal transplant recipients
(RTR) were isolated by Dr E Edmond (University of Edinburgh) during
the course of a CMV study. All patients attended the Nuffield
Transplant Unit, Edinburgh.
(iii) Fifteen HSV isolates from the London area were kindly supplied
by Professor Banatvala, St Thomas's Hospital, London.
Serology
(a) Typing of isolates
The HSV isolates were typed by indirect immunofluorescence as
described by Maitland _et aK (1982). ^ )
(b) Immunoblotting technique
The serology of selected patients was determined in this
laboratory by Dr P Simmonds. C. f S }
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(i) Typing of HSV isolates
Antiserum for typing was prepared in rabbits by immunisation
with HSV 1 strain 1657 (Peutherer J.F. 1970. Journal of Medical
Microbiology _3; 267-272). The serum was adsorbed three times with
vero cells infected with MS strain of HSV 2. The results were
visualised on a Leitz SM Lux microscope with incident UV light.
Infected cells which reacted equally with the unadsorbed and
adsorbed antisera were typed as HSV 1, whereas those reacting only
with the unadsorbed sera were typed as HSV 2.
(ii) Immunoblotting
Vero cells, both uninfected and infected with HSV 1 (strain
1657) or HSV 2 (strain MS) were prepared then lysed with SDS-
mercaptoethanol. The solubilised HSV proteins were then separated
for 4.5 hrs (160v, 25mA) on 10% polyacry1 amide gels with NN-
methyline bis acrylamide cross-1inker. The polypeptides were
electrophoretical 1 y transferred to nitrocellulose which was blocked
with 3% gelatin - Tris buffered saline, then cut into strips. The
strips were reacted with the patient's serum and bound antibody was
detected by incubation with horseradish peroxidase conjugated anti
human serum. The substrate was 4-ch 1 oro-l-napthol obtained from
Biorad.
Isolation and Viral Propagation
(i) Isolation of clinical specimens
All viruses were isolated in Human Embryo Fibroblast Cells
(HEF) by the Virus Diagnostic Laboratory, University of Edinburgh.
(ii) Viral propagation
Viruses were passed to Vero cells grown in MEM (Cruickshank et
al1975) and used for DNA preparation within passage numbers four
to eight. For each virus isolate two sub-confluent Roux bottles of
Vero cells (—50 x 10® eel 1s/Roux) were prepared and inoculated at a
multiplicity of infection (MOI) of approximately 0.1 PFU/cell in
20ml s of MEM. After adsorption for 2 hours at 37°C, a further 30mls
of MEM was added and incubation allowed to continue until a complete
cytopathic effect (CPE) was observed (-16 hours). The infected
cells were subsequently harvested with glass beads, washed twice in
Dulbecco A (Cruickshank et aK, 1975) and stored as a pellet (-70°C)
until used to prepare HSV DNA (Maitland et al., 1982).
(iii) Microcarrier cell culture
Bulk preparations of the standard strains HG52 and 17syn+ were
grown using CYT0DEX 1 microcarriers (Pharmacia). Three grams of
microcarrier beads were prepared (as described by the manufacturers)
then seeded with 4 x 10? Vero eel 1 s in 250ml s of prewarmed (37°C)
MEM. The culture was allowed to settle (with occasional stirring)
for four to five hours when a further 250ml s of MEM was added and
continuous stirring allowed to commence (5-10rpm). A final 500mls
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of MEM was added after two days and replenished in three days time
with fresh (500ml s) MEM. The cells were allowed to grow until
confluent (~6 days) whereby the microcarriers were washed in serum
free MEM then suspended in a minimal amount of MEM containing 1%
(v/v) NBCS before HSV was added at approximately 0.1 PFU/cell.
After adsorption for 2 hours (37°C, occasional stirring), the
culture volume was increased to 500mls with MEM containing 10% (v/v)
NBCS, glucose (2g/l) and non-essential amino acids (as described by
Pharmacia). A further 500mls of MEM (supplemented as above) was
added after 3 days. The culture was stirred until a CPE was
observed (-6 days) then the MEM was removed and the infected
microcarriers were washed in Dulbecco A. The infected eel 1s were
removed by a (1:1) mixture of trypsin (0.1%) - versene (0.02%) -
Dulbecco A solution (pH 7.6) (15 mins, 37°C), then harvested as
recommended by the manufacturer. The eel 1 pel let was washed and
stored at -70°C as previous described.
(iv) Growth and preparation of Adenovirus 2 DNA was as described
by Maniatis et aj_ (1982).
Preparation of HSV DNA
Cell pellets were resuspended in TE (0.01M Tris - 0.01M EDTA,
pH 8) buffer and treated with SDS-Pronase as described by Maitland
et_ a_l_. (1982). The lysates were prepared for density gradient
ultracentrifugati on by adjusting the final volume to 8ml s with TE
containing 0.66% SDS and 80ug/ml of ethidium bromide. Sodium iodide
(7.5g) and sodiurn metabi sul ph i te (50mg/ml ) were then added and the
mixture vortexed before centrifugation at 500g for 10 mins. The
bO
protein-SDS pellicle was then removed and the solution vortexed
before being evenly distributed into 'Quick-Seal' (Beckman)
centrifuge tubes. These were subsequently placed in a VT1-65 rotor
and spun at 50,000rpm in a Beckman L8-55 ul tracentrifuge. Viral DNA
(see Fig 13) was harvested under ultraviolet illumination, by side
puncture of the centrifuge tube. The DNA was extracted as described
by Maitl and et_ aj_. (1982) then resuspended in TE buffer, pH 8.
Restriction Endonuclease Digestion
Approximately lug of viral DNA from all HSV 1 and HSV 2
isolates was digested with a ten-fold excess of the endonucl eases
EcoR I, Bgl11, Hind 111, KpnI, BamHI. In addition, Pvul I and Hpa I
were occasionally used for HSV 1 isolates. All endonucleases were
purchased from NBL Enzymes Ltd. Reaction buffers were as described
by Maniatis e^t a_l_. (1982) except for Kpn I and Hpal which were
prepared as recommended by the manufacturers. All samples were
incubated at 370C for a minimum of 2 hours when the reaction was
stopped by the addition of 1/5th of the volume of loading dye (0.25%
bromophenol blue, 0.15% Ficoll in TE, pH 8).
Agarose gel electrophoresis
O* b C\
(i) Restricted DNA fragments were separated on 0.4^0.8% agarose
(Sigma Type II EEO) gels containing lug/ml of ethidium bromide. The
gels were cast in a horizontal apparatus (40cm x 20cm) and
el ectrophoresed for 16-30 hours at 60v (32mA) in (0.04m) Tris -
(0.005M) sodium acetate - (0.001M) EDTA (pH 7.9) buffer. The gels
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were viewed under short wave ultraviolet transillumination and
photographed with a Polaroid MP5 camera fitted with a Wratten #22
filter.
O-yA.
(ii) Agarose mini-gels (0.8^-1%) were used for the rapid assessment
of DNA concentration and the completion of RE reactions. The gels
were cast on glass si ides (8cm x 8cm) sealed with autoclave tape,
and run in sandwich box tanks at 60v/l00mA for 1-2 hours. The
buffer was as described above.
Transfer of DNA from agarose gels
DNA was transferred either to nitrocellulose (Schleicher and
Schull) or Genescreen (NEN) membrane following the method of Wahl eit
al. (1979), a modification of the Southern technique (1975). After
overnight transfer, the membranes were rinsed in 2 x SSC and baked
between sheets of Whatman 3mm paper for 2 hours at 80OC j_n vacuo.
Estimation of mobility variations
Mobility variations among analogous HSV DNA fragments were
measured from photographs of ethidium bromide stained agarose gels.
Measurement was carried out by using a magnifying lens (x 1.5)
fitted with an internal microscale. The mobility differences were
estimated relative to fragments of known molecular weights.
Analysis of RE data
Analysis of RE site distribution was carried out on an IBM
personal computer, using dBase III.
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Preparation and purification of DNA for probes
(i) Fragments of HSV DNA were either el ectroeiuted into preformed
troughs as described by Maniatis et aj_. (1982), or cut from the gel
and placed in dialysis tubing. The dialysis tubing containing the
gel fragments and TE buffer (pH 8) was placed in a mini-gel tank and
el ectrophoresed for 2 hours at lOOv. The current was then reversed
for 2 mins allowing the DNA on the inside wall of the dialysis
tubing to come into solution. The solution containing the DNA was
filtered through a glass-wool column in order to remove any agarose
fragments. The DNA solution was then extracted with phenol-
chloroform and precipitated overnight with ethanol at -20°C.
(ii) HSV DNA of standard strains or DNA ex tracted from gel
fragments was purified (as above (i)) by using a 'NACS PREPAC'
affinity mini-column (BRL Ltd). The buffer systems for binding and
elution were as recommended by the manufacturer. The eluate was
diluted two-fold with an equal amount of distilled water prior to
ethanol precipitation at -70° for 10 mins. The samples were
centrifuged at 12,000g for 15 mins to collect the DNA pellet. This
was subsequently washed with 70X ethanol and dried under vacuum
before being resuspended in distilled water.
Radioactive labelling of DNA probes
Either standard strain HSV DNA
from agarose gel s were radiolabel 1
Ri gby _et a_l_. (1977). Approximately
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or DNA fragments electroeiuted
ed according to the method of
0.25ug of purified HSV DNA was
mixed with 20uM of dNTP and 2uM (20uCi )(<=< - 3 2 p) labelled dCTP
(Amersham International) in 40ul of reaction mixture containing 50mM
KPO4 (pH 7.4), 5.2mM MgC 1 2» 4mM di thi othrei tol and 17.5u 1 of
distilled water. E. col i DNA polymerase I (8 units) (purchased from
NBL Enzymes Ltd) was added to the reaction mixture and incubated for
1 hour at 150C. The reaction was terminated by the addition of 2ul
of 0.25M EDTA, and the final volume of the DNA probe was made up to
0.1mls with TE buffer (pH 8). Unincorporated nucleotides were
separated by centrifugation through a Sephadex G-50 (Pharmacia)
column prepared as described in Maniatis jat aj_. (1982). The
specific activity of the DNA probe was measured using a Liquid
Scintillation Counter.
Before hybridisation, the 32p_probe was denatured in a boiling
water bath (5 mins), chilled briefly, and made up to 10ml s with 6 x
SSC, 10% dextran sulphate (Pharmacia), 25% formamide, 2.5mM EDTA,
0.5% SDS and 1 x Denhardt's Solution (Denhardt, 1966).
Hybridisation of Membrane Filters
The baked membrane filters were preincubated with 10 x
Denhardt's Solution (Denhardt, 1966) in a heat-sealed polyethylene
bag. After prehybridisation (65°C for 4 hours) in a shaking water
bath, the Denhardt's solution was removed and replaced with the 32p_
labelled probe mixture (4-5 x 10^ cpm/ml). The bag was resealed and
hybridisation allowed to continue for 16 hours at 68°C in a shaking
water bath. The filters were washed twice for a period of 2 hours
in 2 x SSC (640C) and dried for 1 hour at 80°C in vacuo.
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Autoradiography
Autoradiography of the hybridised membrane filters was carried
X-
out for 16 hours - 2 days at -70°C. The films (Kodak^ omat S) were
pre-flashed before use in autoradiography cassettes fitted with
Kodak X-Omatic regular intensifying screens.
Polyacrylamide gel electrophoresis
Viral DNA was digested with either BamHI or Kpnl as previously
described. After the addition of lOul of loading dye (25% w/v
sucrose, 0.2% bromophenol blue) the digests were loaded on to a 3%
(w/v) polyacrylamide stacking gel with a 7.5% (w/v) separating gel
(14 x 19 x 0.15cm) containing 0.05% w/v sucrose. Electrophoresis
was carried out at 50v until the samples entered the separating gel,
when the voltage was increased to 70v (22mA) for 16 hours. The
buffers and conditions were as described by Herring et a_l_ (1982).
Molecular weight standards (0 x 174RF/HaeI11 digests and/or
X/HindIII digests) were included in each gel.
Silver staining of polyacrylamide gels
The gels were stained using a modified version of the technique
described by Herri ng _et a]_. (1982). After removal from the glass
plates, the gel was washed at 20 min intervals with three changes of
10% ethanol - 0.5% acetic acid (500ml s). The gel was then soaked
for 20 m ins in 200ml s of 0.11M silver nitrate solution and rinsed
rapidly in 500mls of distilled water prior to development in 200mls
of 0.75M sodium hydroxide, 0.1M formaldehyde solution. Development
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was allowed for a maximum of 10 mins after which the gel was
enhanced in 500mls of 0.07M sodium carbonate solution (15 mins).
The gel was subsequently placed in a further 500mls of fresh
carbonate solution (2 hrs) before being removed and stored in heat-
sealed polythene bags. The results of each gel were photographed by
transmitted light with a Pentax ME camera.
Non-radiolabel1ed DNA detection systems
(i) BRL DNA Detection System
(a) Preparation of DNA test strips
A stock solution of biotinylated DNA (M13) was diluted with
buffer (5 x SSC, 0.2ug/ul sheared herring sperm DNA) to final
concentration of lOpg/ul , 4pg/ul , 2pg/u1 and lpg/ul. Five ul of
each dilution and 5ul of dilution buffer were sequentially spotted
on nitrocellulose strips (1 x 5cm) then dried for 1-2 hours at 80°C
under vacuum. The test strips were stored dry until used to monitor
the sensitivity of each DNA detection experiment.
(b) Preparation of biotin-labelled DNA probes
Purified DNA was labelled by nick translation in the presence
of bi oti n-ll-dUTP as described by Langer et^ a_l_. (1981). As
recommended by the manufacturer, the BRL nick translation reagent
system was used in the quantities and conditions described in the
accompanying handbook. Once labelled the biotin-DNA probe was
separated from unincorporated nucleotides by gel filtration on a 5ml
Sephadex G-50 (Pharmacia) column. The column was equilibrated with
1 x SSC/0.1% (w/v) SDS before 150u1 fractions of the biotin-labelled
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DNA were collected. Two ul of each fraction was spotted on nitro¬
cellulose strips and dried in a vacuum even at 80OC for 1-2 hours.
Fractions containing labelled DNA were detected by colour
development (as described in (d)) and pooled for use in
hybridisation.
(c) Hybridisation
Conditions were similar to those for radi ol abel 1ed probes and
have been described in detail by Leary et aj_. (1983). The essential
changes are in the reduction of the amount of formamide to 45% and
the low hybridisation temperature (42°C). After hybridisation the
filters were washed twice in 2 x SSC - 0.1% (w/v) SDS (250ml s) for 3
mins at 20°C, then once in 0.2 x SSC - 0.1% (w/v) SDS. The filters
were subsequently incubated in two changes of 250ml s 0.16 x SSC -
0.1% SDS at 50°C for 15 mins each time. After a brief wash in 2 x
SSC - 0.1% (w/v) SDS (20OC) the filters were introduced to the
detection system (see (d) and (e)).
(d) Detection system
The filters were incubated at 42°C for 20 mins in sol ution A
(0.1 M Tris-Cl (pH 7.5), 0.1 M NaCl , 2mM MgCl 2 and °-05% (v/v) Triton
X-100) containing 3% (w/v) BSA. After incubation the filters were
dried under vacuum (10-20 mins, 80°C) then rehydrated in the above
solution before being incubated in BRL streptavadin (6ug/100cm3
nitrocellulose) for a further 10 mins. The streptavidin was removed
and the filters washed (3x2 mins) in solution A before being
incubated in BRL poly (AP) (3ug/100cm2 nitrocellulose) for 10 mins,
then washed (2x2 mins) in solution A. A final washing step (2x2
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mins) was performed with solution B (0.1M Tris-Cl (pH 9.5), 0.1M
NaCl , 50mM MgC^) before the visualisation process.
(e) Visua!isation
Dye solution (NBT and BCIP in solution B) was prepared as
recommended by the manufacturer and sealed with the filter in a
polypropylene bag. The incubation was performed at room temperature
in a dark cupboard and allowed to continue for a maximum of 4 hours.
To terminate the reaction the filters were washed in 20mM Tris (pH
7.5) - 5mM EDTA, then blotted dry and stored. A test strip was used
for each reaction to monitor the colour development.
(ii) Photobiotin Acetate System (BRESA Ltd)
(a) Preparation of the DNA probe
Purified DNA (0.5-lug/ul) was combined with an equal volume of
photobiotin acetate (lmg/ml) in an unsealed microfuge tube, then
placed in a tray of crushed ice. The samples were then irradiated
for 20 mins at 10cm beneath two Crompton 250 watt mercury-tungsten
lamps. After irradiation the reaction mixture was made up to a
final vol ume of lOOul with lOOmM Tris-Cl , l.OmM EDTA (pH 9), then
extracted twice with an equal volume of butan-2-ol. DNA was
recovered by the addition of 5u 1 (3M) sodium acetate and lOOul of
ethanol (-20°C). After 16 hours the solution was centrifuged in a
micro-centrifuge (15 mins, 4°C) to yield the labelled DNA pellet.
The pellet was washed in 70% (v/v) ethanol, dried j_n vacuo and




The hybridisation conditions used have been described in detail
by Forster et al (1985).
(c) Colorimetric detection
The filters were blocked with BSA solution and treated with
avidin-alkal ine phosphatase (under the conditions decribed by BREAS
Ltd) then washed (in solution A) to reduce non-specific binding and
added to the substrate solution (NBT-BCIP) for a maximum of 4hours.
The reaction was terminated in lOmM Tris-Cl, l.OmM EDTA (pH 7.5) and
the filter blotted dry before being stored. A photobiotin-1abel 1 ed
DNA control (M13) was spotted on each filter and used to monitor the
colour reaction.
Preparation of Viral DNA for Use with Photobiotin
(i) HSV DNA (HSV 1 and HSV 2) was prepared and purified as
previously described.
(ii) CMV DNA prepared from urine specimens (Chou and Merigan,
1983) was kindly supplied by Dr E Edmond.
(iii) HPV DNA was prepared from frozen wart specimens (supplied by
the Department of Dermatology, University of Edinburgh) by a
modification of the method of Rud 1 i nger et_ _al_. (1986). The warts
were resuspended in 1ml of Hirt buffer to which lOOug of predigested
pronase (Sigma) was added. The warts were then incubated (37°C, 2
hours) before the addition of a further lOOug of pronase. After
overnight incubation (37°C) l/5th of the volume of 5M NaCl was added
and the samples held at 40C for 10 mins (12000g) and the supernatant
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removed to a glass tube. After three extractions with phenol -
chloroform (1:1) the DNA was precipitated overnight with ethanol (-
20°C). The DNA pellet was then washed in70% ethanol (3 times),
dried under vacuum and resuspended in TE buffer (pH 8). The cloned
HPV DNA for probe preparation was amplified by the method of
Birnboim and Doly (1979) then the DNA precipitated at -20°C (16
hours) with ethanol.
(iv) HBV DNA was prepared from serum samples supplied by Dr JF
Peutherer, Hepatitis Reference Laboratory, University of Edinburgh.
The procedure used (a modification of Landers et_ aj_. 1977) was
carried out at 4°C on a Spinco-L centrifuge. Seven mis of serum
were clarified by centrifugation for 10 mins at 2,000rpm (SW40
rotor). Five mis of the supernatant was then removed and combined
with 5ml s of TNEMBSA buffer. The mixture was then centrifuged for 2
hours (SW40 rotor, 35,000rpm, 4°C) to pellet the DANE particles.
The pellet was resuspended overnight (200ul TNEMBSA, 4°C) before
being layered on a 20% sucrose gradient and spun at 40,000rpm for 2
hours (SW40 rotor, 40C). The pellet was again resuspended overnight
(lOOul 0.01M Tris - 0.1M NaCl (pH 7.5), 40C) then pelleted through a
30% sucrose gradient at 42,000rpm for 3 hours (SW50 rotor, 40C).
After resuspension in lOOul 0.01M Tris - 0.01M EDTA, pH 7.5 (4°C
overnight), the pellet was incubated (37°C) with (2mg/ml) protease
and 0.6% SDS for 90 mins. The preparation was subsequently phenol-
chloroform extracted (3 x) and ethanol precipitated at -20°C for 72
hours. The DNA was collected, vacuum dried, and resuspended in TE
(pH 8) buffer.
O Q\M eo-/\




1. Microcarrier Cell Culture
The use of CYTODEX 1 microcarriers (see Methods) was
investigated as a method for the production of bulk preparations of
standard strain (HG52 and 17 syn+) HSV DNA. A summary of the time
for preparation and yield of HSV DNA produced by microcarrier cell
culture compared with that of the more conventional production in
Roux bottles is shown in Table 4.
Growth of vero cells in Roux bottles was carried out routinely
in the laboratory and required a total volume of 300mls of MEM. HSV
was added at a multiplicity of infection (MOI) of O.lpfu/cel1 giving
a yield of 1 x 10~^ug of HSV DNA per cell (Table 4).
Growth of vero cells on microcarrier beads (Fig 14) was carried
out under the conditions recommended by the manufacturers (see
materials and methods) and required a total volume of 3 litres of
MEM. Using the same MOI as in Roux bottle culture (O.lpfu/cel 1 )
produced a cytopathic effect (CPE) in approximately 6 days. During
this time a number of vero cells had become detached from the beads,
however 6 days was the minimum time for a good CPE to be produced.
The yield of HSV DNA after harvesting was found to be approximately
6.25 x 10-3Ug/cell.
In an attempt to reduce the time taken to produce a good CPE by
microcarrier culture an MOI of lpfu/cell was used. In this instance
a good CPE was observed after 5 days, however purification of the
DNA on a sodium iodide gradient (Fig 13) revealed a large band of









Vero cells one day after inoculation onto Cytodex microcarriers.
( X120)
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Table4 Comparisonfcellulturemethodsandyielfthproducti nfHSVDNA TotalnocellsN fcel satTimetak nY eldof Methodofr quireftimefvir sforproductionHSVDNA/T talme ia cellulturese dinoculumfCPEce lrequirement 2Roux bottles12x060107hrs10730 mls Microcarrier culture4x10'-*401 76days.25x106
31itres
The method of microcarrier cell culture was discontinued due to
the expense of the media and the time required for production of
DNA.
2. The reproducibility of agarose gel electrophoresis with
standard laboratory strains
In order to determine the reproducibility of the technique^
preparations of standard strain DNA (HG52 and 17syn+) were prepared
(as described in Materials and Methods), digested to completion with
appropriate restriction enzymes then separated by agarose gel
electrophoresis. The experimental design was as follows:
(a) standard strain DNA (HG52 and 17syn+) prepared from a single
preparation was examined on a number of occasions to allow
determination of reproducibility.
(b) standard strain DNAs from 3 separate preparations were
repeatedly run in parallel tracks on agarose gels, thus
allowing a compari son of both reproducibility and variation
between consecutive DNA preparations.
In both cases (a and b) the overall restriction endonuclease profile
remained constant, with no major variations observed between
preparations or on successive electrophoresis. Small mobility
differences were noted in fragments g (HG52) and k (17syn+) that
occur in the joint region of the genome. The following studies
therefore use only major variations as a criteria for distinguishing
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HSV isolates. However, mobility differences have been noted and are
discussed in section 3c and 4.
3. Analysis of DNA from Genital Isolates of Herpes Simplex Virus
1 and 2
(a) Patients
(i) Time of isolation of HSV 1 and HSV 2
During the 19 month period from 1st January 1982 to 31st July
1983, HSV was isolated from 224 patients with clinical evidence
of herpetic infection. The patients were new attenders at the
clinics held by the Department of Genitourinary Medicine (RIE) and
South Fife Hospitals. The viruses were isolated and typed as
described in the methods section, with 24.4% (44) found to be HSV 1
isolates. The monthly isolations of HSV 1 and HSV 2 are represented
in Figure 15. Overall the number of first isolations for HSV 2
ranged from 3-22 per month, whereas those of HSV 1 ranged from 1-4
per month, having averages of 9.5 and 2.3 isolations per month
respectively. A comparison of the isolations for the first seven
months of each year showed only one notable difference in the month
of Jur\«2 1982 when 23 isolates (1 HSV 1, 22 HSV 2) were obtained.
The peak isolation (22) of HSV 2 samples was recorded in July 1982,
while in July 1982 the isolations of HSV 1 exceeded those of HSV 2.
(ii) Age and sex distribution
Consideration of age and sex distribution (Fig 16) demonstrates
that for HSV 2 isolates the ages of the male patients ranged from 18
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Figure 15
Isolation of HSV (types 1 and 2) from genital lesions during the
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to 72 years (average 31.2 years), while the female patients were
aged from 14 to 47 years (average 25.2 years). Similarly for the
HSV 1 isolates (Fig 17), the average age of the male patients was
25.6 years with a range of 18-35 years, whereas the female patients
ranged from 18-37 years, having an average age of 22.3 years. The
ratio of male to female patients for HSV 1 and HSV 2 was found to be
1:3.4 and 1:0.75 respectively.
(iii) Source of virus isolates
Virus was isolated ma inly from lesions of the skin or mucous
membranes of the genital tract with two exceptions, one from a urine
sample, the other from lesions on the buttocks. The distribution of
sites for virus isolation (Table 5) from male patients shows that
the majority of HSV 2 samples were isolated from the prepuce
(39.9%), for HSV 1 samples the prepuce and anus shared an equal
number of isolates. In the majority of female patients HSV 2 was
isolated from the cervix (25.9%), whereas the vulva was the most
common isolation site (41.2%) for HSV 1 infections (Table 6).
Further consultation of clinical data showed that 33 females were
recorded as having HSV isolated concurrently from the cervix and
another genital site.
Thirteen HSV 2 and 9 HSV 1 specimens whose recorded site of
isolation was a genital site (as described in Table 6b) also had a
positive cervical isolation. In addition, 11 specimens (10 HSV2, 1
HSV 1) whose recorded site of isolation was the cervix also had a
concurrent genital isolation from an unspecified site. Despite
adjustment for these figures, the vula was still found to be the
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Figure 17
The age and sex distribution of patients with genital HSV I
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Table 5
Anatomical sites of isolation for male patients with genital HSV
(103 HSV 2, 10 HSV 1).
Site of isolation Number of HSV 2 Number of HSV 1
(as detailed by isolations isolations
the request form) (%) (%)
Peni s 13 (12.6) 2 (20)
G1 ans 3 ( 4.8) -
Coronal sulcus 11 (10.7) -
Prepuce 41 (39.9) 3 (30)
Frenum 3 ( 2.9) -
Urethra 8 ( 7.8) _
Urine - 1 (10)
Anus 5 ( 4.8) 3 (30)
Thigh 1 ( l.o) _
Buttocks 1 ( l.o) -
Not specified 15 (14.5) 1 (10)
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Table 6
(a) Anatomical sites of isolation for female patients with genital
HSV (77 HSV 2, 34 HSV 1)
Site of isolation Number of HSV 2 Number of HSV 1
(as detailed by isolations isolations
the request form) (%) (%)
Cervix 20 (25.9) 5 (14.7)
Vul va 13 (16.9) 14 (41.2)
Labia 18 (23.4) 6 (17.7)
Fourchette 4 ( 5.2) -
Introitus 7 ( 9.1) 1 ( 2.9)
CI itoris 3 ( 3.9) 1 ( 2.9)
Perineum 1 ( 1.3) 3 ( 8.8)
Anus 3 ( 3.9) 1 ( 2.9)
Not specified 8 (10.4) 3 ( 8.8)
(b) Number of female patients from whom HSV was isolated
concurrently from genital (as 6a) and cervical sites.
Anatomical site Number of HSV 2 isolates Number of HSV 1 isolates
of isolation with positive cervical with positive cervical
isolation isolation
Vul va 4 3
Introitus 2 -
Labi a 3 2
CI itoris 1 1
Fourchette 2 -
Perineum - 2
Not specified 1 1
Total 13 9
10 HSV 2 specimens and 1 HSV 1 specimen recorded as having been
isolated from the cervix also had a concurrent genital isolation.
6 patients recorded as having HSV 2 isolated from the cervix had
negative genital isolations, while 13 patients with positive genital
isolations had negative virus isolation from the cervix.
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most common isolation site for HSV 1 infections in female patients.
However, for HSV 2 isolations the cervix, vulva and labia may share
equal numbers of successful HSV isolations from female patients.
(b) Restriction endonuclease analysis
The fragment nomenclature used throughout is that of Davison
and Wilkie (1981) determined for the Glasgow standard strains
17syn+ (HSV 1) and HG52 (HSV 2). All 224 HSV isolates were examined
with five restriction endonucleases EcoRI, Bglll, Hindi 11, Kpnl and
BamHI as described in the Methods section. Any new sites or fusions
were initially determined by simple molecular weight additions.
However hybridisation experiments were carried out (an example of
which is shown in Fig 18) to verify the map positions of new sites
or fusions and to enable distinction between major variations (Fig
€) and simple mobility differences (Figs 33, 34). The data obtained
from the agarose gels (e.g. Figs 19-24) are summari sed in Tables 7
and 8 for HSV 2 and HSV 1 isolates respectively. Map positions for
the major RE variations are also represented in Figs 25 (HSV 2) and
26 (HSV 1). Specific RE data for each isolate is listed in the
Appendix.
(i) Analysis of HSV 2 isolates
On the basis of addition or deletion of specific enzyme
recognition sites the 180 HSV 2 isolates were divided into 18 groups
as shown in Tables 9a and b. No further distinction could be made
between the HSV 2 isolates purely on the basis of variable site
combinations as identified with the five endonucleases.
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Figure 18
Autoradiogram of HSV 2 DNA digested with Hind111 and separated on a
0.4% agarose gel. Hybridisation with 32p_i abel1ed EcoRI-o fragment
(see methods) confirmed the presence of an m-1 fusion in track D.
Tracks A-C - prototype RE profile
Track D - m-1 fusion






Prototype tracks A, B and C demonstrate hybridisation of HindHI
fragments k, 1, c and <A with EcoRI-0. Track D, with an m-1 fusion,
shows hybridisation of an additional band (the fusion fragment) at
5.5kbp. The quarter molar fragment k is not easily visual ised in
this autoradiograph.
Figure 19
Agarose gel showing Hind 111 digests of HSV 2 DNA from genital
isolates.
Tracks A, B - prototype RE profiles











Agarose gel showing Kpnl digests of HSV 2 DNA from genital isolates.
Tracks A, B - d-i fusion







Agarose gel showing Bgl 11 digests of HSV 2 DNA from genital
isolates.
Track A - prototype




Agarose gel showing Hindlll diqest of HSV 2 DNA from Genital
isolates.
Track A - new site in fragment a (,x)




Agarose gel showing Hindl11 digests of HSV 2 DNA from genital
isolates.
Track A - new site in fragment e







Agarose gel showing Hindl 11 digests of HSV 1 DNA from genital
isolates.
Track A - o-h fusion
























i 1 = fusion
4, r new site
m, = new site in m (2.6/0.4)
m2 = new site in m (1.8/1.1)
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Figure 26


























Description and frequency of major variations in the restriction
endonuclease sites of 180 genital HSV 2 isolates
Variable site Number of isolates (%)
EcoRI f-j 81 (45)
Bglll c (13/3) 4 (2.2)
p-r 1 (0.55)
Hindlll e (9/2) 21 (11.7)
m-1 1 (0.55)
a (11/9.5) 1 (0.55)
Kpnl d-i 147 (81.6)
m (3.1/0.9) 1 (0.55)
BamHI w (1/1) 79 (43.9)
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Table 8
Description and frequency of major variations in the restriction
endonuclease sites of 44 genital HSV 1 isolates
Variable site Number of isolates (%)
EcoRI h-k 3 (6.8)
k (2.0/1.5) 7 (15.9)
1 -a 1 (2.3)
HindiII o-h 14 (31.8)
k-1 1 (2.3)
m-n 5 (11.4)
Kpnl s-d 42 (95.4)
p-v 3 (6.8)
b (6.2/1.8) 40 (90.9)
9 38 (86.9)
m (2.6/0.4) 13 (29.5)
m (1.8/1.1) 9 (20.4)




a (7.2/0.8) 22 (50)
a (5.8/2.2) 12 (27.3)
1 (1.7/1.8) 1 (2.3)
m (2.8/0.4) 3 (6.8)
o (2.4/0.2) 2 (4.5)
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Table 9a
Variations in the restriction endonuclease profiles of genital HSV 2
(DNA) isolated between 1.1.82 - 31.7.83
Digestion patterns when
restricted with:
EcoRI Bgl11 Hindl11 Kpnia
BamHI

















a = The order of digestion is, reading from left to right, EcoR I,
BgllI, Hindl11, KpnI. Where p indicates prototype (as HG52), x
indicates the following: for EcoRI, loss of f-j site; for
Bgl11, extra site in c fragment; for Hindl 11, extra site in e
fragment; for Kpnl, loss of d-i site.




Unique variable RE sites found in genital HSV 2 (DNA) isolated
between 1.1.82 - 31.7.83
Isolate Number EcoRI BgllI Hind111 Kpnl BamHI
1465 P P P d-f <->
12928 f-j P m-1 d-i (-)
15762 P P-r P P (+)
7561 f-j P a d-i (-)
P = prototype
- = fusion between the restriction fragments as stated for each
enzyme
a = new site in Hindi 11 a fragment giving two new fragments of
molecular weights 11 and 9.5Kbp
*"m = new site in KpnI m fragment giving two new fragments of
molecular weights 3.1 and 0.9Kbp
(-) = absence of BamHI w fragment
(+) = presence of BamHI w fragment
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(ii) Analysis of HSV 1 isolates
All 44 HSV 1 isolates could be distinguished from each other
solely by the criteria of site additions and deletions as identified
with the five endonucleases. A detailed description of the variable
restriction endonuclease sites is provided in Table 8.
(iii) Computer comparison of variable RE sites
A computer comparison (for both HSV 2 and HSV 1 isolates) of
the frequency of RE site variation with sex (male vs female) or
anatomical site of isolation (extra-genital sites vs genital sites)
revealed no differences in either the frequency or the distribution
of RE sites (data not shown). No correlation was found when the
frequency of the variable sites recognised by the restriction
enzymes were compared with "CW W Y-v C"C \ c. y^cv\ G j- tWe_
(c) Fragment variability generated by restriction endonuclease
digestion
During the course of the study the restriction patterns of
digested HSV 1 and HSV 2 DNA revealed variation in the
el ectrophoretic mobi1ity of several fragments (Figs 27, 28). The
mobility differences were recorded and the map positions of the
variable fragments are shown in Figs 29 and 30 for HSV 1 and HSV 2
respectively. Most variation in both HSV 1 and HSV 2 isolates was
found in the L-S junction and terminal fragments of the genome. The
el ectrophoretic mobilities observed with BamHI L-S junction
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Figure 27
Agarose gel showing mobility differences obtained by digestion of
HSV 2 DNA with EcoRI.
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Figure 28
Agarose gel showing mobility differencesobtained by digestion of HSV 2
DNA with Bgl II.
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Figure 29
The map positions of HSV 1 DNA fragments exhibiting mobility













The map positions of HSV 2 DNA fragments exhibiting mobility








fragments g (HSV 2) and k (HSV 1) not only varied in mobility but
also in the number of bands generated.
Variations were also observed in the Ul region (e.g. HSV 1
EcoRI m and 1, Hi ndlIIj *HSV 2, Kpnl o and i) and the Us region
(e.g. BamHI n and x HSV 1) in a minimum of 2% of all isolates
examined. However, several of these fragments were located adjacent
to fragments in the joint or terminal repeat regions (e.g. HSV 2
BamHI c and x).
4. Mobility Variations in the Restriction Endonuclease Profiles of
Clinical HSV Isolates
In order to determine the extent of variation in the
electrophoretic mobility of restriction endonuclease fragments with
site and/or time, selected groups of DNA preparations were digested
to completion with the appropriate restriction endonucleases, then
separated on agarose gels (as described in Methods section). The
experimental design and specific groups were as follows:
(a) examination for variation of 8 HSV 1 viruses isolated
concurrently from different anatomical sites of 3 patients
(Table 10).
(b) examination for variation of 8 HSV 2 viruses isolated
concurrently from different genital sites of 4 patients (Table
11).
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F=female DoB=datefBir h Dol=dateofIs la ion a=theorderfdigestioniEcoRI,BgIII,Hindl11,Kpnwhereind cat s prototype(asHG52),xindicatethefollowing:rEc RI,l sf- site;forBglll,ext aiincragment;HindIIIt efragment;orKpnl,lossfd-isite, w=indicatespresence(+)orabsenc-fB mHIfrag t
(c) A study of 14 sequential HSV 1 isolates from 7 patients (Fig
31) enabled examination of variation between the isolates of
individuals over various time periods (Table 12).
Full clinical details of the patients in groups a, b and c are
listed in Tables 10-12, however the REA of HSV 1 isolates are listed
in the Appendix. RE maps for each endonuclease are provided for
reference in the Appendix.
For each group (a, b and c) consistency of the overall
restriction profile for each patient was observed with one
exception, patient M3493 in Table 12. In this instance sequential
genital HSV 1 isolates 4639 and 11849, obtained within a 5.9 year
interval, were observed to differ in the deletion of KpnI m
fragment. Variations due to the el ectrophoretic mobility of several
fragments were noted for all isolates in groups a, b and c (as
indicated in Tables 10-12), occurring mainly in the L-S junction or
terminal fragments. In one instance (E1593, Table 10) the Kpnl e
fragment exhibited a decreased electrophoretic mobility between
sequential isolates, to such an extent that the fragment mobility
may mistakenly have been interpreted as a major variation.
5. Restriction Endonuclease Analysis of HSV DNA from Sexual
Consorts
HSV DNA was prepared from 27 pairs (29 male, 25 female) of
sexual partners with clearly defined clinical histories and whose
serological status has been determined (see Methods). All 54
s am pies (42 HSV 2, 12 HSV 1) were initially ex am in ed 'blind' in an
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Figure 31
Agarose gel showing Kpnl digests of HSV 1 DNA from sequential
genital isolates.
Tracks A, B - 2787, 6075
Tracks C, D - 4639, 11849
Tracks E, F - 3422, 8935
Track G - standard strain 17syn+
A B C D E F G
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Table12 ClinicalandREd tofsequentialg it lHSV1isola esfr m7p ti ts
MajorREobi1ity




















































S=theseisolateshavdenticalm jorrestr ctionzymprofil +=indicatespresenceofK nlmfragm t -=indicatesabsenceofKp lmfragm nt
attempt to trace the transmission of HSV between sexual consorts.
After obtaining the RE data, the clinical and serological background
of each patient was examined to assess the significance of the
results.
(a) HSV 1 isolates
The twelve HSV 1 isolates could be divided into seven separate
groups on the basis of major variations as determined by the five
restriction endonucleases EcoRI, Bgl II, HindIII, Kpnl and BamHI (Fig
32). In five cases the virus profiles from paired sexual consorts
were identical, however the remaining pair of isolates (1728, 2028)
each had entirely different RE profiles. By reference to the
serological and clinical data (Table 13), isolate 2028 was from a
male patient who had suffered oral herpes 28 days before isolation
of virus number 2028. In this instance the virus responsible for
the oral lesion in the male patient may have been transmitted to the
genitalia of the female consort during oro-genital sex. Isolation
of virus 2028 from the male patient may therefore be caused by
reactivation of a latent virus.
Three pairs of sexual consorts with primary serology had the
same major RE profile as that of their respective consort (Table
14). This may be easily explained in two of the three cases where
recent sexual partners other than the named consort were admitted.
However in 1403/1399 no other sexual partners were admitted.
Transmission of HSV may therefore have occurred by oral contact from
a family member or unnamed individual.
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Figure 32
Agarose gel showing BamHI digests of HSV 1 DNA from paired sexual
consorts.
Track A - 1728
Tracks B, C - paired consorts 3079, 3088
Tracks D, E - paired consorts 4022, 4024
A B C D E
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Table 13
Clinical, serological and RE data of paired sexual consorts from










1403 M _ 5 widespread lesions P S
1399 F - 5 widespread lesions P
4024 M - 10 penile herpes P S
4022 M - 10 anal herpes N-P
8039 F - 2 vulval herpes P S
8059 M - 3 penile herpes N-P
1728 F _ NA vulval herpes P D
2028 M - NA oral herpes 28 days N-P
before isolation
3088 M + 4 penile herpes P S
3079 F - 5 vulval herpes P
3280 F + NA vulval herpes P S
3349 M — NA penile herpes P
M = male
F = female
a = + evidence of a recent sexual partner other than the named
consort;
- no evidence of a recent sexual partner other than the named
consort
b = time interval in days between last intercourse with named
consort and virus isolation
P = primary infection; NP = non-primary infection
REA = restriction endonuclease analysis where S indicates the same




Restriction endonuclease analysis of HSV 1 (DNA) from paired sexual
consorts




































P = prototype Re profile (as 17syn+)
- = fusion between the restriction fragments as stated for each
endonuclease
b = new site in Kpnl b fragment giving two new fragments of
molecular weights 6.2 and 1.8Kbp
g = new site in KpnI g fragment giving two new fragments of
molecular weights 5.2 and 1.8Kbp
ml = new site in Kpnl m fragment giving two new fragments of
molecular weights 2.6 and 0.4Kbp
m2 = new site in Kpnl m fragment giving two new fragments of
molecular weights 1.8 and 1.1 Kbp
al = new site in BamHI a fragment giving two new fragments of
molecular weights 7.2 and 0.8Kbp
a2 = new site in BamHI a fragment giving two new fragments of
molecular weights 5.8 and 2.2Kbp
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(b) HSV 2 isolates
Specific epidemiology proved to be very difficult with HSV 2
isolates due to the lack of major variations in their RE pro files
(Table 15) (Figs 33, 34). In an attempt to clarify the
relationships of some of the HSV 2 viruses, the clinical and
serological data were examined in detail. In this instance 24
isolates were from patients who had either been involved in complex
sexual relationships, or recorded a lengthy time interval between
intercourse with the named consort and successful virus isolation
(Tables 16, 17, 18). The remaining 18 isolates (9 pairs of sexual
consorts) appeared to have no such complications (Table 18).
(i) Primary index cases with complications
Table 16 shows three primary index cases and their named
consorts. In al 1 three instances a sexual partner other than the
named consort was admitted. Virus isolation in two of the three
couples occurred at the same time or within a time interval of a few
days. For the remaining couple (2437/9221) the female (9221) had an
HSV isolation recorded in May 1984, although her regular partner had
no isolation at this time. A previous specimen from the regular
partner (2437) was isolated in March 1983 during a primary herpetic
infection and could therefore be used for RE comparison. In all
three pairs of named sexual consorts the RE profiles were found to
be the same as that of their respective partner.
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Figure 33
Agarose gel showing mobility differences in fragments g, p, q etc.
on digestion of HSV 2 DNA with BamHI♦
Track A - unrelated isolate
Tracks B, C - paired sexual consorts 13826, 9833
Tracks D, E - standard strain HG52
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Figure 34
Agarose gel showing mobility differences in BamHI digests of HSV 2





























Fragment g appears as 2 bands, whereas fragments pq, st,
all appear as separate bands with variable mobilities.
vw and
Table 15
Variations among 42 HSV 2 (DNA) isolates from sexual consorts
Digestion pattern
when restricted with: BamHI
Number of virus











a = The order of digestion is, reading from left to right, EcoRI,
Bgl 11, HindIII, Kpnl, where p indicates prototype (as HG52), x
indicates the following: for EcoRI, loss of f-j site; for
Hi ndIII, extra site in e fragment; for Kpnl, loss of d-i site.
b = BamHI digestion pattern indicates presence (+) or absence (-)
of fragment w.
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F=female a=seefootnotefT bl13 b=seefootnot sandfT ble15 NA=notavailable P=primaryinfection N-P=non-primaryinfection I=initialfection
Table 17
Clinical and serological details of paired sexual consorts (13826
and 9833) with primary serology
Date Male (13826) Female (9833)
12.02.81 - Negative serology, no virus
isolation
— .11.81 Casual relationship with
unnamed partner
17.12.81 Penile ulcer, primary
serology, no virus isolation
09.02.82 - Primary serology, no virus
isolation
03.03.82 - Primary serology, no virus
isolation
11.03.82 - Serology not available,
virus isolation of 9833
12.03.82 No virus isolation
31.08.82 Virus isolation of 13826
from buttocks

























































































F=female N-P=non-primaryinfection a=seefootnotnTable13 b=timeintervaldaysbetweenlastint rcou sewithnam dconsortdvi us isolation c=seefootnotesadbnTable15
Another couple (13826/9833; Table 17) both had evidence of
primary infections. In this instance the samples used for RE
analysis were isolated in 1982 after a recurrence. Both 13826 and
9833 were found to have the same major RE profile of ppppw+.
(ii) Non-primary index cases with complications
The source patients of four pairs of sexual consorts had non-
primary serology and admitted to being involved in other sexual
relationships (Table 18). Two pairs of isolates (11784/3163 and
2662/3825) had identical RE profiles, however the isolates from the
remaining two pairs of consorts each had a different RE profile from
that of their named sexual partner. In these cases either virus
transmission from an unnamed individual or reactivation of a latent
virus may have taken place.
(iii) Uncomplicated non-primary infections in paired sexual
consorts
Four pairs of sexual consorts, who on interview were recorded
as having a stable relationship with the named sexual partner, were
found to have non-primary infections (Table 19). All but three
patients had clinical signs and symptoms of herpetic infections.
Three of the four couples were found to have identical RE profiles
on the basis of major variations. The remaining couple (3561/4989)
had entirely different RE profiles from each other, despite having
admitted to no other recent sexual relationships.
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Table 19
Clinical, serological and RE data from paired sexual consorts with




Virus no Sex (days)3 symptoms Serology REA
2884 M 21 penile herpes N-P pppxw
2971 F 22 genital herpes N-P
3561 M 4 penile herpes N-P ppppw
4898 F 2 vulval herpes N-P xpppw
11010 M NA none N-P pppxw
11640 F NA none N-P
15900 M 6 penile lesions N-P ppppw
16492 F NA none N-P
a = see footnote a of Table 13
b = see footnotes a and b of Table 15




(iv) Uncomplicated primary or initial index cases
Nine pairs of sexual consorts with primary or initial index
cases were recorded as having a stable relationship with the named
sexual partner (Table 20). One couple (7358/7495) were involved in
homosexual practices. In all nine cases the RE profiles for each
pair of sexual consorts was identical on the basis of major
variations.
Two patients, 104 (male A) and 6801 (female A) were
subsequently involved in a rather complex sexual relationship as
shown in Fig 35. Couple A (104/6801) were proven to have the same
virus strain by RE analysis of virus isolates in 1982. In 1983,
6801 was involved with another male (B) who was in contact both with
his wife (B) and another female (B). Virus isolations from male B
or wife B were unsuccessful, however isolate 3283 from female B was
examined by RE analysis. In this instance 3283 was found to have
the same profile as 104 and 6801 (ppppw-).
6. Oro-genital HSV isolations
(a) Patients
Ten male patients (20-27 years) presenting with genital herpes
or anal warts were found to have herpetic infections of the mouth.
All patients had clinicl manifestations as characterised by
tonsillitis (4), ulceration of the mucous membranes (3) and healing
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Figure 35












12.10.83 MALE B (P6608)







Clinical, serological and RE data from paired sexual consorts with
primary or initial index cases who were in a stable relationship
with the named sexual partner
Time
interval Signs and
Virus no Sex (days)3 symptoms Serology REA
9049 M 11 penile ulcers P
+
xppxw
9167 F 28 vulval lesions N-P
2884 21 penile herpes I pppxw"
2971 F 21 herpetic ulcer N-P
10080 7 penile herpes P ppppw"
11071 F NA none NA
12963 F 4 penile herpes P pppxw"
12929 4 vulval herpes P
6801 F 9 vulval herpes P ppppw"
104 19 penile blisters N-P
2597 5 penile lesions P xppxw+
3097 F 25 anal sores N-P
19 6 penile herpes P xpxxw"
30 F 7 vulval herpes N-P
6779 10 penile herpes P xppxw+
6593 F 7 vulval herpes N-P
7358 M 12 anal herpes I xppxw"
7495 M 14 oral herpes N-P
= see footnote a of Table 13
= see footnotes a and b of Table 15
M = mal e
F = female
P = primary infection
N-P = non-primary infection
I = initial infection
NA = not available
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lesions on the lips (4). Other symptoms such as malaise, fever and
gingivitis were also common. Nine patients yielded HSV from both
oral and genital lesions while the tenth, a traced consort of a
patient with genital herpes, yielded HSV from the throat. The
isolates were all typed by immunofluorescence with ten (from five
patients) found to be HSV 1 and the remaining nine to be HSV 2. All
of the HSV 2 infections occurred from 1982 onwards with two of the
patients admitting to homosexual practices.
(b) Serology
All five patients from whom HSV 1 had been isolated were found
to be suffering primary infections (Table 21). Three of the five
patients with HSV 2 infections were found to have a primary
infection (Table 22), and of the remaining two patients one had an
initial infection, whereas the other (P5612) was recorded as having
had antibody to HSV 2 one year previously. No further clinical
evidence was available in this instance to ascertain whether this
was a first infection of the oral region.
(c) Restriction endonuclease analysis
HSV DNA was prepared from both the oral and genital specimens
of each patient then analysed by the restriction endonucl eases
EcoRI, Bg1 II, Hindl 11, KpnI and BamHI. On the basis of major RE
variations all the HSV 1 genital isolates could be paired with that
of the oral isolate from each respective patient. In each case a
unique viral profile was obtained (Table 23). Examination of the
HSV 2 isolates (Table 24) showed that isolates from three of five
Table 21
CIinical and serological data of 5 male heterosexual patients from
whom HSV 1 had been isolated from both oral and genital sites
Patient Age Oral presentation
Antibody
Genital presentation status
P7829 20 Enlarged tonsils Enlarged glands,
herpetic ulcers
P
P6842 24 Herpes of the 1 ips Penile ulcers P
P6032 32 Herpetic ulceration
of the tongue
Penile ulcers P
P2958 26 Herpetic ulceration









P = primary infection
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Table22 Clinicalandserologicald tfor5patientsr mwhomHSV2hb nisolated fromralandge italsites Sexual PatientSexAgepracticeOral presentation
Genital presentation
Antibody status
S592 P9968 P8863 P5612 P4259
20Heterpeticulc rat on ofrighttonsil 26Hornerpeticulcerat on oftonsils 27Heterpeticlesionso tongue 22Hornerpesfthupper lip 20HetUlcerationof tonsils
Penileulcer lymphadenopathy Herpeticulcera ion ofanusdscrotum Herpeticlesionso penis Analwarts Penileulcers Enlargedglands
N-P
M=male Het=heterosexual Horn=hom sexual P=primaryinfection
I=initialfection N-P=non-primaryinfection
Table 23
Restriction endonuclease analysis of HSV 1 (DNA) isolated from
patients with oral and genital lesions
Patient EcoRI Bglll 1Hindi II Kpnl BamHI
















P2958 a-k P o-h s-d al
b j'-b1i




P = prototype RE profile (as 17syn+)
- = fusion between the restriction fragments as stated for each
endonuclease
b = new site in Kpnl b fragment gi ving two new fragments of
molecular weights 6.2 and 1.8Kbp
g = new site in Kpnl g fragment giving two new fragments of
molecular weights 5.2 and 1.8Kbp
ml = new site in Kpnl m fragment gi ving two new fragments of
molecular weights 2.6 and 0.4Kbp
al = new site in BamHI a fragment giving two new fragments of
molecular weights 7.2 and 0.8Kbp
a2 = new site in BamHI a fragment giving two new fragments of
molecular weights 5.8 and 2.2Kbp
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Table 24
Restriction endonuclease analysis of HSV 2 (DNA) isolated from
patients with oral and genital lesions
Patient EcoRI Bglll Hindi11 Kpnl BamHIw
S592 P P P P ( + )
P9968 P P P d-i ( + )
P8863 P P P d-i ( + )
P5612 f-j P P d-i (-)
P4259 P P P d-i ( + )
P = prototype RE profile (as HG52)
= fusion between the restriction fragments as stated for each
endonuclease
(+) = presence of BamHI w fragment
(-) = absence of BamHI w fragment
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patients could not be distinguished solely on the basis of major
variations.
(d) Comparison of the major RE profiles found in oro-genital HSV
isolates with those from solely genital sites
Comparisons of the most common variable sites found in oro-
genital and genital isolates are shown in Table 25a and b for HSV 1
and HSV 2 respectively. No notable differences were observed
between the HSV 1 genital and oro-genital sites, however one site
Kpnl m (1.8/1.1) was not found in the oro-genital isolates. For
HSV 2 isolates the frequency of Kpnl d-i fusion was similar for both
genital and non-genital isolates, however, the frequency of sites
EcoRI f-j and BamHI w (1/1) in the genital isolates was more than
double that of the oro-genital isolates. A larger sample of oro-
genital isolates would be required for confirmation of these
results.
7. HSV Isolations from Patients in London
Fifteen herpes simplex virus isolates were examined from
persons living in the London area. Six of the HSV 1 isolates were
from individuals (4 nurses B13-16 and two patients B17, 18)
associated with a nosocomial outbreak in the intensive care unit of
a London hospital. The remaining three HSV 1 and six HSV 2 isolates
were random specimens from London patients.
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The DNA from all 15 isolates was examined by five restriction
endonucleases EcoRI, Bgl II, Hindi 11, Kpnl and BamHI. Tables 26 and
27 show the RE data for HSV 1 and HSV 2 isolates respectively.
Three HSV 1 isolates, from one nurse (B16) and two patients (B17,
18) appeared to have the same RE profile, whereas the remaining
three isolates (B13, 14, 15) had unique RE profiles and were not
infected with the same HSV 1 strain as B16, 17 and 18 (Fig 36). The
HSV 1 isolates from a random selection of individuals (B6, 9, 10)
again showed a unique RE profile for each isolate.
By comparison, the DNA from six random HSV 2 isolates did not
have unique RE profiles and therefore only one (B4) could be
distinguished from the others on the basis of major variations
(Table 27).
Consideration of the distribution of variable sites found in
London isolates compared with those found in Edinburgh isolates is
shown in Table 28. The HSV 1 isolates showed considerable variation
between the Edinburgh (genital) and London (non-genital) isolates,
with three of the seven most common variable sites not being found
in the London isolates. In the remaining four sites only two (BamHI
a (7.2/0.8) and d-h) showed a similar distribution between the
London (non-genital) and the Edinburgh (genital) isolates. For HSV
2 (genital) isolates, only 2 of the 3 most common variable sites
were found in the London isolates (Table 28b). As with the HSV 1
isolates, the distribution of variable sites in the HSV 2 isolates
was found to differ between the London and the Edinburgh isolates,
but may in part be due to the small number of isolates sampled.
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Figure 36
Agarose gel showing BamHI digests of HSV 1 DNA isolated from










- patient B, intensive care unit
- patient A, intensive care unit
- nurse B, intensive care unit
- nurse A, intensive care unit









Restriction enconuclease analysis of HSV 1 (DNA) isolated from
nurses, patients and other individuals in the London area
Virus no EcoRI Bglll Hindi 11 Kpn I BamHI
w
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prototype RE profile (as 17syn+)
fusion between the restriction fragments as stated for each
endonuclease
new site in KpnI b fragment giving two new fragments of
molecular weights 6.2 and 1.8Kbp
new site in KpnI g fragment giving two new fragments of
molecular weights 5.2 and 1.8Kbp
new site in KpnI m fragment giving two new fragments of
molecular weights 2.6 and 0.4Kbp
new site in BamHI a fragment giving two new fragments of








Restriction endonuclease analysis of HSV 2 (DNA) isolated from
London inhabitants
Virus no EcoRI Bglll Hind 111 Kpnl BamHI
w
B1 P P P d-i ( + )
B2 P P P d-i ( + )
B3 P P P d-i (+)
B4 f-j P P d-i (+)
B5 P P P d-i ( + )
B8 P P P d-i ( + )
P = prototype RE profile (as in HG52)
= fusion between the restriction fragments as stated for each
endonuclease
(+) = presence of BamHI w fragment
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8. HSV in Renal Transplant Recipients
(i) Patients
During the study of 50 renal transplant recipients HSV was
isolated from the throat swabs of 27 patients (13 male, 14 female)
with an age range of 31-60 years (average age 47 (male), 35.5
(female)). Fifteen of the 27 patients (56%) received a combination
of cyclosporine (CsA) and prednisolone (P) with the remaining 12
(44%) were treated with azothioprine (A) and prednisolone.
Figure 37 illustrates the time interval between receiving a
transplant and the first isolation of HSV from the throat swabs of
patients receiving CsA/P compared to that of the
azothiopri ne/predni sol one (A/P) treated patients. Individuals on
CsA/P therapy were found to shed the first virus isolate within a 9
week period, with the majority of patients shedding virus between 1-
4 weeks. However, those patients treated with A/P had a first virus
isolate as late as 12 weeks after treatment.
All 27 patients were sampled at regular intervals for a
minimum of 6 weeks after transplant, although those patients on A/P
were fol 1 owed for a longer period. During this period 8 patients
were defined as shedding HSV, since a number of sequential HSV




The time interval between transplantation and first isolation of HSV














(ii) Restriction endonuclease analysis
Forty four HSV 1 samples isolated from throat swabs of 16 (9
male, 7 female) renal transplant recipients were examined by RE
analysis using EcoRI, Bg1 II, Hindlll, KpnI and BamH I restriction
enzymes. The pre-transplant antibody status was determined in 13 of
the patients (Table 29); the remaining three patients had no serum
available for testing.
(a) Possible Transmission of Virus Infection in an Open Ward
Three of the 16 RTRs (Fig 38) all yielded HSV during treatment
in an open hospital ward. Patient LL, from whom HSV had been
isolated a few weeks before transplant, was treated in an open ward
beside patients EMcI and DC. Several weeks later all three patients
yielded HSV from throat swabs (see Fig 38). By examination of the
RE profiles of the HSV DNA from each patient (Fig 39), it was
established that all three individuals had been suffering from a
unique HSV 1 strain and therefore no transmission of HSV 1 had
occurred within the ward.
(b) The Possible Transmission of HSV from Infected Kidneys to
Recipients
Ten individuals received a kidney from 5 cadavers, however only
two receiving kidneys from the same cadaver suffered HSV infections
after transplantation (Fig 40). Both subsequently had a nephrectomy
after three months. In order to determine whether both patients had
been infected with an identical strain of HSV, the RE profiles of
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Figure 38
HSV isolations from renal transplant recipients *ho had been
treated in an open ward
LL
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Restriction endonuclease profiles of HSV 1 DNA isolated from renal























H = Hindi 11
New sites and fusions are as described in Table 14.
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Figure 4Q
HSV isolations of 2 renal transplant recipients who had received
a transplant from the same cadaver
±L —HHH
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RE=restrictionendonucleases *=timeofnephrectomy **=postnephrectomy NA=notavailable +=antibodytoHSVdetec edbyComplem ntFix tiont st
the HSV 1 DNA from each patient was examined (Fig 41). In this
instance a different RE profile was obtained for each patient,
therefore no common HSV 1 strain was responsible for infection. In
both cases HSV was isolated solely from throat swabs and antibody
was present before the transplantation. No information regarding
the HSV antibody status of the donor was available.
(c) RE Analysis of HSV Isolates from Three Patients Shedding Virus
HSV DNA from three patients were examined by RE analysis.
Patient JR (Fig 42) was sampled over a 14 month period and found to
shed virus over six months. Patient IG was sampled over a nine
month period, shedding virus over six weeks, as did patient DL who
was sampled over four months. All positive HSV isolations were
examined by RE analysis with the exception of one, which was not
available (patient IG). The RE profiles of six samples from JR and
5 samples from DL showed no major variations in sequential isolates
from each patient. Examination of four isolates from IG showed a
major variation in the RE profile of one isolate, occurring in the
unique long segment of the genome (Kpnl m fragment) (see Appendix).
Comparison of the RE profiles from all three patients (Fig 43)
showed that each had a different HSV 1 strain.
(d) RE Profiles of the sixteen renal transplant recipients
Examination of sequential isolates from all 16 RTRs showed that
each patient had a unique strain of HSV 1 as determined by the RE
profiles (see Appendix), and with one exception (IG) demonstrated
no major variations in sequential virus isolations from the same
144
Figure 41
Restriction endonuclease profiles of HSV 1 DNA from two renal
transplant recipients who had received a transplant from the same
cadaver.
.Kmj R s-d K g






New sites and fusions are as described in Table 14.
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Figure 42
Patients shedding HSV over a period of six weeks or more
JR H-HH-HH--- - HH" H' - H - -
DL HHH-HH- --
IG-HH-H H - H*
012345 10 15 20 25 30 35







Restriction endonuclease profiles of 3 renal transplant recipients





JH = Hi ndl 11
New sites and fusions are as described in Table 14.
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individual. Consideration of the variability of RE sites for
patients receiving A/P therapy compared to CsA/P therapy
demonstrated no significant difference either in the number or
distribution of RE sites (data in Appendix).
(e) Comparison of the Frequency of the Most Variable RE Sites in
Non-genital (RTR) and Genital Isolates
Table 30 illustrates the frequency distribution of non-genital
HSV isolates compared with genital HSV isolates from the Edinburgh
area. Only three (BamHI a (5.8/2.2), BamHI d-h, Kpnl m (1.8/1.1))
of the seven most variable sites were found to have the same
frequency of distribution in both genital and non-genital isolates.
The most notable difference was found in Kpnl m (2.6/0.4) site where
the frequency of the non-genital isolates was almost double that of
the genital isolates (see Table 30).
9. Polyacrylamide Gel Electrophoresis (PAGE)
Polyacrylamide gel electrophoresis of selected HSV DNA samples
was carried out then stained with an ultrasensitive silver stain as
described in the Materials and Methods. Using standard strain DNA
(H652 and 17syn+) the reproducibi1ity of the technique was
established, then by using different preparations of the standard
strain DNA (Fig 44) any variable fragments were noted. Small
molecular weight fragments were easily detected with good resolution
particularly in the regions of the genome ranging from 2-0.5Kbp.
Fragments of molecular weight standard 0 x 174RF/HaeI11 were
extracted from agarose gels, purified (see Materials and Methods)
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Fi gure 44
Polyacrylamide gel electrophoresis of standard strains (17 (HSV 1)
and HG52 (HSV 2]) and sequential HSV 1 isolates from Renal
Transplant Recipients.
Tracks A, 0X174RF/ HaeIII ; B, 17 (BamHI) ; C, 17 preparation 2
(BamHI) ; D, repeat of track B ; E, HG52 (Bgl 11) ; F, HG52 (BamHI)
; G,H, patient JR 138,98 (BamHI) ; I,J, patient LL 613,558 (BamHI)
;K-N, patient DL 850,822,7317772 (BamHI).
0-3
Table30 Thefrequ ncyofvariableREsit sinon-ge ital(re atr splantrosw bs)a dg italHSV1 * isolates BamHIIBamHIIKpnlHind II nSitea(7.2/0.8)(5.8/2.2d-hm(2.6/0.4)1 8/1.1)o-h (16)Non-genital0. 225.10. 2.5025 (RTR) (44)Genital0.502716.290. 132 *Thevaluesintablrx/n,wh resnumb rofis latesh vingtv riablet ,di thenumberofisolatese chgroup.
then run on a pol yacryl amide gel. In each case the molecular weight
fragment ran to approximately the same distance as that shown by the
respective fragment of 0 x RF174 on the polyacrylamide gel (data not
shown.
(a) Variations in RE profiles from sequential oral and genital HSV
isolates
(i) Eight HSV 1 samples isolated sequentially from throat
swabs of three renal transplant recipients JR, DL and LL, were
digested with either Kpnl or BamHI and examined by pol yacrylamide
gel electrophoresis as described in the Materials and Methods. The
results for electrophoresis are shown in Figs 44 and 45, however the
clinical and serological data have been described previously (see
Table 29). Figure 45 shows consistency of mobility and number of RE
fragments for sequential isolates from patients JR and DL when each
sample was digested with Kpnl. Examination of the same samples with
BamHI (Fig 44) revealed very small mobility differences for patient
DL (Tracks K-N) in fragments of- i.35-1.4Kb. A similar difference
was also noted between the sequential isolates from patient JR.
However, examination of sequential isolates from a third patient,
LL, found no variation at this position. Several differences in a
number of high molecular weight fragments were noted between Tracks
I and J.
(ii) Sequential HSV 1 samples isolated from the
genitalia of two individuals were digested with BamHI and examined
by PAGE as shown in Tracks LMN of Fig 45. Samples 8935 and 3422
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Figure45
Polyacrylamide gel showing : KpnI digests of sequential HSV 1
isolates from Renal Transplant Recipients (B-G) ; Kpnl and BamHI
digests of sequential genital isolates (H-N) and standard HSV 1
(17) DNA.
Tracks A, 0X174RF / Haelll ; B,C, patient JR 98, 138 ;
D-G, patient DL 772,791,822,850 ; H, 961 (Kpnl) ; I, HSV 2 (Kpnl) ;
J, 17 (Kpnl) ; K, HSV 2 (BamHI) ; K, 961 (BamHI) ;
M, 8935 (BamHI) ; N, 3422 (BamHI) ; 0, 17 (BamHI).
Mwt ABCD EFGHIJKLMNO
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(paired sequential isolates) had identical RE profiles that revealed
no apparent mobility differences. The RE profiles of 8935 and 3422
differed substantially from that of 961 (Track L) an unrelated
isol ate.
(b) Variations in the RE profiles of HSV from paired sexual consorts
(i) Eight HSV 1 and eight HSV 2 samples isolated from eight
pairs of known sexual consorts, were digested with BamHI then
examined by PAGE. (The clinical and serological data for these
samples have already been described in Tables 12 and 13). By
reference to the standard strain 17syn+, fragment deletions and
extra fragments were denoted as (0) or (X) for HSV 1 isolates, as
shown in Figure 46. Tracks B and C revealed identical RE profiles
with no mobility differences observed. Unfortunately tracks B and D
were very faint and cannot be seen clearly in the figure provided.
Tracks F and G exhibited similar RE profiles, however trace bands in
track F are attributed to small amounts of host DNA in the sample.
Variations between isolates H and I were found in the form of an
extra band (in Track I) of approximately 1.5Kb.
(ii) Similar studies with HSV 2 isolates from paired sexual
consorts revealed mobi 1 ity variations between paired isolates as
indicated by (O) on Figure 47. Several fragments were observed to
differ between isolates D and E (at approximately 1.8Kb) that could
not be attributed to host contamination or an incomplete digestion
pattern. Examination of tracks F and G also revealed differences in
mobility and number of restriction fragments, despite the small
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Figure46
Polyacrylamide gel showing BamHI digests of HSV 1 DNA from paired
sexual consorts.
Tracks A, 0X174RF / Haelll ; B, 4024 ; C, 4022 ; D, 3088 ;





Polyacrylamide gel showing BamHI digests of HSV 2 DNA from paired
sexual consorts.
Tracks A,X/ Hi nd 111 ; B, 19 ; C, 30 ; D, 11010 ; E, 11640 ;






quantity of DNA in Track F. No comparison of Tracks H and I could
be clearly obtained due to insufficient amounts of sample (Track I)
avai1able.
10. Colorimetric Detection of Biotin-labelled Nucleic Acids
(a) Sensitivity
Nitrocellulose filters were spotted with biotinylated standard
DNA, baked, then subjected to the colorimetric procedures described
in the Materials and Methods section. After one hour a blue-
coloured precipitate formed in the solution, attaching on to the
nitrocellulose. After 4.5 hours incubation only one dot (50pg) of
biotinylated DNA developed. This procedure was repeated with fresh,
filtered buffers and the same result was obtained. Two subsequent
colorimetric solutions obtained from BRL produced the same results.
A final dye solution provided by BRL produced a slightly better
result with the 50pg dot developing in a 30 min period.
Precipitation of the dye solution still occurred (Fig 48a) and
produced a background coloration, nevertheless after 5 hours
incubation a faint outline of the lOpg dot could be observed. The
dye precipitation was subsequently delayed by prewarming the dye
solution to 37°C before use, however dye precipitation still
occurred in approximately 40-45 mins.
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Figure 48a
Dot-blots of the standard (M13) DNA as detected by the BRL
detection system showing precipitation of the dye solutions.
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(b) Colorimetric detection of biotin-1abel1ed nucleic acid probes
after hybridisation to immobilised nucleic acids
Purified pBR322 DNA was nick translated then dotted on to
nitrocellulose and developed using the colorimetric procedure in
order to determine the labelled fraction of the biotin-DNA probe.
The probe was then used at a concentration of lOOng/ul and
hybridised to pre-baked filters dotted with dilution buffer,
standard biotin-DNA, and pBR322 DNA at concentrations ranging from
120ug-6ug of DNA. The colorimetric detection system was continued
as before for a maximum of 5 hours. After 3 hours dots appeared at
120, 60 and 30ug fractions, however it took a further 2 hours
development to produce faint dots in the 18 and 12ug fractions. Dye
precipitation was again experienced in this and repetitions of this
experiment. Southern blots of DNA were also used in the detection
procedure (as described in the Materials and Methods section),
however no clear results could be obtained due to dye precipitation
and high background colour development.
11. Colorimetric detection of photo-biotin-1abel1ed nucleic acids
spotted on to nitrocellulose
(a) Sensitivity
Nitrocellulose filters were spotted with dilutions of
biotinylated sheared salmon sperm DNA at concentrations ranging from
200-5pg then baked, hybridised and developed using the colorimetric
procedure described in the Materials and Methods section. Within
30 mins the 50pg dot was fully developed, with the 5pg dot
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developing in approximately 2 hours. No background coloration was
observed and no dye precipitation occurred.
(b) Colorimetric detection of nucleic acid probes after
hybridisation to immobilised nucleic acids
The specificity of photobiotin was examined by studying the
reactions of photobiotin labelled viral nucleic acid probes. The
experimental design was as follows:-
(i) Detection of HSV DNA probe binding
Nitrocellulose filters were spotted with: (1) biotinylated M13
DNA (2pg, lpg), (2) purified standard strain 17syn+ (HSV 1) DNA, (3)
dilution buffer, (4) uninfected vero cells DNA, (5) clinical samples
of HSV 1 DNA, (6) standard strain HG52 (HSV 2).
Figure 48b shows that the HSV 1 photobiotin labelled probe
reacted both with HSV 1 and HSV 2 samples but did not react with
dilution buffer o run infected cellular DNA. This result is not
surprising considering the homology between the HSV 1 and 2 genomes.
The limit of detection for HSV DNA was approximately lOpg. After
drying the colour of the dot blots faded, however the results could
be recorded accurately by photography under a white light source
(Fig 48b).
(ii) Detection of HPV DNA probe binding
Photobiotin labelled HPV 2 DNA probes were hybridised to: (1)
HPV DNA (HPV 1, 2, 6) extracted from clinical wart specimens that
had previously been typed by agarose gel electrophoresis and 32p_
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Figure 48b
Photobiotin dot blot of HSV DNA, hybridised with standard strain
17syn+ and photographed under incident (a) and transi 11uminated (b)
white light.
Dilution buffer - A1
17 syn+ - A2
Vero cell DNA - A3, B3
HSV 1 DNA (2028) - A4, B4
Standard M13 DNA - A5, B5
HSV 1 DNA (3280, 1728) - Bl, CI
HG52, HSV 2 DNA (11011) - B2, C2
no samples - C4, C5,C3
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labelled probes, (2) pBR322 DNA, (3) dilution buffer, (4)
biotinylated M13 DNA.
Figure 49 shows that the HPV 2 photobiotin labelled probe
reacted both with its vector, pBR322 DNA, and the DNA previously
typed as HPV 2 DNA extracted from wart specimens, the HPV 2 probe
was able to detect 5pg of HPV DNA in clinical specimens.
(iii) Detection of CMV probe binding
Figure 50 demonstrates that the purified Hindl11 1 fragment of
CMV reacted specifically with CMV DNA isolated from urine specimens
that had previously been identified by cell culture. In each case
for the clinical CMV specimens the DNA of approximately 105 cells
( 50ng) were spotted on to the nitrocellulose. Samples VS and JB
gave very weak results with the detection procedure. No reaction
was observed with HSV or uninfected HEF cells.
(iv) Detection of HBV probe binding
HBV-DNA was hybridised to two positive HBV samples (R1529,
R1524) and one negative sample (R1123) provided by the Hepatitis
Reference Laboratory. After preparation and purification of the DNA
(as described in the Materials and Methods) an average of O.Olug of
DNA was isolated from each sample. Dilutionsof lOpg, 5pg, 2pg
amounts were spotted on to nitrocellulose filters, as was dilution
buffer. After hybridisation with HBV clone and development in the
dye solutions for 2hrs the lOpg dot appeared in the positive sample
R1529. A faint result was obtained for R1524 after a further hours
development in the dye solution. No reaction was apparent for the
negative sample R1123 or the dye solution (results not shown).
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Figure 49
Photobiotin dot blot of HPV DNA, hybridised with HPV 2 clone and
photographed under incident (a) and transi 1 1uminated (b) white
1ight.
Al, 2, 3 - HPV 2 DNA C3
A4 - pBR322 DNA C4
A, B, CD5 - standard M13 DNA D1
Bl, 2, 3 - wart sample HE (HPV 6) D2
B4 - wart sample ZA (HPV6) D3, 4
CI, 2 - dilution buffer
- sample R (HPV 1)
- sample P (HPV 1)
- sample M (HPV 2)
- sample B (HPV 2)
- no sample
Figure 50
Photobiotin dot bot of CMV DNA, hybridised with HindIII-1 fragment
and photographed under incident (a) and transi 11uminated (b) white
1ight.
A1 - sample MB CI - standard AD169 DNA
A2 - sample VS C2 - HSV 1 DNA
A3 - sample KMc C3 - HSV 2 DNA
B1 sample JB D1 - dilution buffer
B2 sample WS D2 - cell pellet





1. Microcarrier Cell Culture
The production of HSV DNA by microcarrier cell culture proved
to be a costly and time consuming when compared with traditional
methods of cell culture (Table 4). Microcarrier culture is
advantageous in that the cells are cultured as monolayers on small
particles suspended in growth medium, therefore large areas can be
cultured in a small volume. However, to obtain optimum yields and
enhance growth the cultures require constant stirring as well as a
rich medium supplemented with 10% calf serum. During the growth of
the cells in any culture system the concentrations of various
essential components (glutamine, glucose, etc.) are consumed at
different rates and require to be replaced by a complete medium
change which al so helps to maintain the optimum pH. However, in
microcarrier culture vessels this process requires a large volume of
medium (Table 4). The attachment of cells to microcarriers is a
fairly slow process dependent on the number of effective collisions
between the cells and the beads. The multiplication rate is,
however, only slightly greater than that in stationery culture as
shown in Table 4. Unlike stationery cultures in Roux bottles, the
microcarrier cell culture required 5-6 days before a monolayer was
obtained (Table 4).
After inoculation with HSV (0.1 pfu/cel1 ) a CPE was observed in
six days. The total time required for the development of a CPE is
obviously important in the production of non-defective HSV DNA,
si nee the yield of HSV DNA/cell for microcarrier culture is poor
compared with standard culture in Roux bottles (Table 4). The
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infection of the cells on the microcarriers, using a constant virus
inoculum and volume, must be dependent on the number of collisons
with the cells. If this is the case, all the cells cannot be
infected at the same time, since the microcarrier beads have a large
surface area.
During the 6 days necessary for the production of a CPE several
cells had become detached from the beads. This may explain the
relatively poor average yield of DNA/cel1 obtained by microcarrier
cell culture compared to the more conventional Roux bottle
production (Table 4). In an attempt to decrease the time taken to
produce a CPE in microcarrier culture, the MOI was increased to 1
pfu/cell. Although a CPE was observed in 4 days this method
produced large quantities of defective DNA which was unsuitable for
use in RE analysis. The production of large amounts of defective
DNA in microcarrier culture is comparable to that seen in static
culture methods when a high MOI is used.
2. Restriction Endonuclease Analysis
Restriction endonucleases have provided an invaluable tool in
the study of the molecular epidemiology of the herpes viruses,
allowing differentiation of subtypes (A1 1 en _et a_L, 1983a; Pirtle
et aj_., 1984) and epidemiological tracing of virus (Buchman et al.,
1978, 1979; Brown, 1980; Huang _et 1980; Sakaoka et_ al.,
1984).
In herpes viruses variations in RE patterns are considered to
occur in two forms:
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(i) major variations corresponding to the addition or deletion
of restriction endonuclease sites
or
(ii) minor variations attributed mainly to mobility
differences.
For epidemiological studies much controversy exists about the
reliability of using mobility differences for determining
epidemiological rel atedness of isolates (Smith _et a_l_., 1981;
Roizman and Tognon, 1982; Barton et_ aj_., 1985). Various
laboratories have reported alterations in the RE cleavage of herpes
virus DNAs after passage in cell culture (Huang et aj_., 1980; Hirai
et_ _al_., 1981; Zweerink et_ a_l_., 1981; Roizman and Tognon, 1983).
These changes appeared as variations in the el ectrophoretic
mobilities of restriction fragments occurring mainly at the joint
and terminal regions of the genomes. Similar studies in PRV have
also indicated that mobility variations (ranging from 100-400Kb) can
be detected with non-plaque purified strains after vitro (Allen
et_aj_., 1983b) or in vivo passage (Mengel i ng _et a_l_., 1983; Wathen
and Pirtle, 1984). However, genomic changes resulting from loss or
gain of sites during serial passage have not been reported (Roizman
and Tognon, 1982; Allen et aj_., 1983b).
The results of the study in Edinburgh are in agreement with the
findings of the aforementioned authors. Examination of the
reproducibi1ity of the electrophoretic patterns of standard strain
HSV DNA, both from a single preparation and after serial passage in
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Vero cells, revealed no variations in the major RE profiles.
However, mobility variations of RE fragments were observed mainly
from the junction of the genome (e.g. Bam g (HSV 2) K (HSV 1)) (see
Results Section 2).
I Genital HSV isolations from a single clinical centre
(a) Source of isolates
Despite numerous epidemiological studies of HSV (Buchman et
a 1 ., 1978 and 1979; Hal perin et_ a_l_., 1980; Hammerberg et_ a 1 .,
1983) most groups have either examined a small number of isolates
(Table 2) or have concentrated on HSV 1 strains (Chaney et al .,
1983b; Sakaoka et a_l_., 1984 and 1985). At present only two large
scale studies of HSV 2 strains have been attempted. The first by
Mai tl and _et_ a_l_. (1982) considered 65 genital specimens isolated
sequentially from 30 patients attending a single clinical centre
(Royal Infirmary, Edinburgh (RIE)). However, the second by Chaney
et_a_l_. (1983a) involved only 38 patients from two geographically
distinct areas in Canada.
In comparison to other authors, this study examines the DNA
sequence complexity of 224 strains of HSV (180 HSV 2, 44 HSV 1)
isolated from 224 patients who attended the Department of Genito¬
urinary Medicine (RIE) between 1.1.82 and 31.7.83. The proportion
cy£.v\v*Cc\\
of/HSV 1 isolates ( 20%) during this time period is in good
agreement with previous published figures for the Edinburgh area
(Smith et al_., 1973). As HSV 1 was isolated more often from females
(Smith et _al_., 1973) than males during the study period it may be of
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epidemiol ogicaly significance, since HSV infection is presumably
derived from saliva by oro-genital contact.
Although this project was not set up as an epidemiological
study, it was observed that greatest number of isolations appeared
to occur in June and July 1982 for HSV 1 and HSV 2 isolates
respectively (Figure 15). This is somewhat surprising since
Edinburgh experiences a large influx of visitors in August during
the International Festival, therefore August and September would
have been expected to be the prime months of isolation. This was
certainly the case for Neisseria gonorrhoea specimens isolated from
patients attending the Department of Genito-uri nary Medicine (RIE)
during 1982 (Reid, 1985).
The site of isolation detailed by the request forms (Tables 5,
6a) showed that the prepuce was the most common site of isolation
(both for HSV 1 and HSV 2) in male patients. For the female
patients the isolates were most frequently obtained from the vulva
and the cervix for HSV 1 and HSV 2 isolations respectively.
However, the analysis is complicated by the fact that isolations
were attempted from the cervix and from clinical sites of infection
(Table 6b). In some cases the cervix alone was tested in the
absence of signs of genital lesions (Table 6b).
(b) Restriction Enzyme Analysis
Digestion of all viral DNA samples with five restriction
endonucleases (EcoRI, Bgl11, Hindl11, KpnI, BamHI), for which
published RE maps are available, allowed the DNA sequence varations
*
169
to be mapped to specific locations on the genome. More importantly,
use of RE maps eliminated any possibility of misinterpreting
heterogeneity of the junction and terminal fragments as major
variations.
The results of the analysis confirm those of previous studies
(Maitl and £t 1982; Sheppard _et aj_., 1982; Chaney et al .,
1983a) in that the HSV 2 DNA showed relatively infrequent variation,
with either one or two site deletions/additions being found with
each RE (Tables 7, 9a and b). Greater variation was detected with
the multicut endonuclease BamHI, but the majority of these
variations were found to be in the terminal or sub-terminal
fragments.
The complexity of the analysis with multicut endonucleases
emphasises the need for published RE maps when attempting
epidemiological analysis. Strain differentiation in this study was
therefore based solely on the presence or absence of specific
restriction sites and not on the variations in themobility of RE
fragments, although mobility variations were recorded as shown in
Figures 29 and 30.
(i) HSV isolates
The HSV 2 isolates from 180 patients were ranked according to
their digestion patterns with four enzymes (EcoRI, BglH, HindIII,
Kpn I) then subdivided by BamHI digestion (Table 9a). Within the
population studied the pattern pppx predominates (65 isolates) with
the subdivision for BamHI w~ being the most common (35 isolates).
This is contrary to a previous study of the Edinburgh area (Maitland
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et £l_., 1982) when xppx appeared to be the most common RE pattern,
occurring in 13 of the 30 patients examined (Table A, Appendix). In
this instance no classification for the BamHI w~ subdivisi on was
attempted
The present study of 180 patients should reflect a more
accurate analysis of strain variation within the Edinburgh
population. Maitland _et aj_. (1982) also considered that the linkage
of EcoRI f-j with KpnI d-i structure may be important in the
Edinburgh area. Indeed, comparison of the results of this study and
those of Maitland et_ _al_. (1982) reveal ed that 56% of the isolates
had both f-j and d-i fusions, while the sample of Chaney et a 1.
(1983a) had only 47% of the isolates with this linkage (Table B,
Appendix).
Certain configurations are predominant within the Edinburgh
area. The frequency of RE variations (Table B, Appendix) found
during the study indicates that the most frequent major variation is
Kpnl d-i fusion, occurring in 81% of the isolates. This is similar
to the 83% reported by Maitland _et aj_. (1982) and slightly less than
the 89% of Chaney et_ a_l_. (1983) (Table B, Appendix). In all three
studies the Bgl11 restriction endonucl ease sitas were the most
invariable. It should be noted that several major variations were
detected during the course of this study that have not previously
been reported (Table 9b). These variations have been confirmed by
molecular hybridisation experiments and increase the total number of
variable sites in HSV 2 DNA to nine, as detected by the five
restriction endonucleases stated (Table 7).
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(ii) HSV 1 isolates
All 44 HSV 1 isolates were found to have unique RE profiles as
determined by the five restriction endonucleases. A total of 21
major variations were detected (Table 8); less than the total found
by Chaney ejt a_l_. (1983b) with the same enzymes. This may be a
re flection of the sensitivity of the 3 2 p label led DNA techniques
(Lonsdale £t a_l_., 1979) compared to that of the sodium iodide
•~Ce>r
purification (Wal boomers and/ Shegget, 1976) used in the present
study. However, it may also be due to geographical variation since
Chaney et a_l_. (1983b) studied HSV isolated from Canadian patients.
As with the HSV 2 isolates Bgl11 restriction patterns were
relatively invariable. The most common site variation was found in
95.4% of the isolates occurring at the KpnI s-d site (Table 8).
This is marginally less than the frequency reported by Chaney et al.
(1983b) (Table C Appendix). Comparisons of the variations found in
HSV 1 isolates from the Edinburgh area with those of Chaney et a 1.
(1983b) are shown in Table C (Appendix). As in previous studies
different frequencies of variation are found among the isolates from
different geographic locations.
The distribution of variable sites in HSV 1 and HSV 2 isolates
were compared for isolations from males and females as well as for
anatomical sites (genital/extragenital). However, no differences in




Variable length fragments are frequently used in the
identification of epidemiologica 1 1 y related strains and to
distinguish epidemiological ly unrelated HSV 2 strains (Chaney et al ,
1983a; Davis et_ aj_., 1985). During the study of 224
epidemiological ly unrelated HSV isolates mobility variations were
found mainly in fragments that occur in the terminal or junction
regions of the genome (Figs 29, 30, 33, 34). However, other
variable fragments were noted in the unique long and short regions
of the genome (Figs 29, 30). Such variations have previously been
observed both in cloned stocks of the same virus strain (Roizman and
Tognon, 1982) and in clinical isolates (Chaney et_ aj_., 1983a).
Chaney et_ a_L (1983a) used variable length fragments Bgl 11 i and
BamHI y (fragments that are not observed to differ in cloned stocks)
in an attempt to distinguish 30 HSV 2 isolates. The authors
expected that the length of these variable fragments could help to
define strain relatedness. However, comparison of isolates by
geographical origin and sex of patient provided no such information
regarding either variable length fragments or RE site distribution.
Similar observations have also been made with several other
herpes viruses (Allen et aU 1983a; Mengel i ng et a_l_., 1983; Pirtle
et aJL, 1984) and have led the the authors to believe that variable
length fragments should not be used as a criteria for
differentiation (Roizman and Tognon, 1982 and 1983).
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In an attempt to study the extent of variation in the
electrophoretic mobility of restriction endonuclease fragments with
site and/or time, selected groups of DNA preparations were examined
(Tables 10, 11, 12). In al 1 but one patient the major RE pro files
of concurrent and sequential isolates were identical. The one
exception occurred inpatient M3493 (Table 12) where sequential
genital HSV 1 isolates (obtained within a 5.9 year interval) were
observed to vary in the Kpnl m site. In this instance the patient
M3493 did not have reactivation of a latent virus but had been
reinfected with a different HSV 1 strain.
Mobility variations occurring mainly in the joint or terminal
fragments were also noted between sequential isolates. In one case
(E1593, Table 12) the decreased electrophoretic mobility of Kpnl e
fragment could easily have been mi sinterpreted as a major variation.
The decreased electrophoretic mobility of the Kpnl e fragment has
previously been reported in plaque purified stocks of standard
strain MP-I (Roizmc^ and 1983).
111 HSV in sexual consorts
The examination of a closely monitored population of 27 index
patients and their sexual consorts provided information on the
natural history of HSV infections between known sexual partners. In
contrast to work presented by other authors (Davi s _et 1985;
Mertz et_ aj_., 1985; Rooney et_ aj_., 1986; Table 2) this study
considers 54 patients from whom clearly defined clinical histories
had been obtained and immunological status established (Tables 13,
17, 19, 20).
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In an attempt to trace the transmission of virus between sexual
consorts, all 54 isolates (42 HSV 2, 12 HSV 1) were intially
examined 'blind' without consideration of clinical or serological
data. By using only major variations the REA could easily pair 10
of the 12 HSV 1 isolates (Table 14). Consultation of the clinical
and serological data revealed that the two isolates (1728, 2028)
with different RE profiles were obtained from a couple who were in a
steady sexual relationship. In this instance the male patient, with
non-primary serology, suffered oral herpes 28 days before isolation
of virus 2028 from the penis. The female partner, from whom HSV had
been isolated from a vulval lesion, may have been infected from the
oral lesion of the male during oro-genital sex (Table 13). If this
was the case, the HSV isolated from the penis of the male patient
would be a reactivation of a latent virus and therefore would be a
different infection from that observed in the female partner.
Isolations of concurrent and concomitant HSV infections have
previously been reported (both for Type 1 and 2 HSV) by other
authors (Maitland et aj_., 1982 ; Lewis et aj_., 1984).
Epidemiological tracing of the 42 HSV 2 viruses proved to be
much more difficult due to the lack of variable RE sites in the HSV
2 genome (Table 15). In order to clarify the relationship of some
of the virus isolates, the clinical and serological data were
examined but it became apparent that only 13 of the 21 sexual pairs
could reliably be used for the purpose of epidemiological tracing
(Tables 16, 17, 18, 19, 20).
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Eight pairs of sexual consorts admitted to have had a sexual
relationship with other unnamed individuals (Tables 16, 17, 18).
The remaining 13 pairs were from stable relationships, with no other
sexual partners admitted (Tables 19, 20). In four of the eight
cases (Tables 16, 17), where there was evidence of sexual
relationships with unnamed individuals, the index patients were
found to have primary serology. In one instance (Table 17) both the
index patient and the regular sexual consort had primary serology.
All four pairs were found to have the same major RE profile as that
of their respective named sexual consort, despite having had
intercourse with unknown individuals. The source patients of the
remaining four pairs of consorts involved in sexual relationships
with individuals other than the named partner, had non-primary
serology (Table 18). Two of the four pairs had identical RE
profiles, however the remaining four isolates (1333/13468,
12667/11259) from two pairs of known consorts, had entirely
different RE profiles. Presumably in these cases the infection
occurred either by transmission from a previous sexual relationship
or by reactivation of latent virus strains.
Restriction enzyme analysis of the HSV isolates from the 13
couples who were involved in stable sexual relationships revealed
that 12 of the 13 pairs had identical RE profiles (Tables 19, 20).
The remaining couple (3561/4989) (Table 19) despite having had no
other recent sexual involvement had different RE profiles. Since
both individuals had non-primary serology, presumably each was
infected by their own latent virus which had been acquired
previously.
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Other authors have examined HSV transmission in sexual consorts
using RE analysis (Table 2) but only one group, Mertz et _al_. (1985),
considered the patients' clinical and serological status. This may
not be of particular importance in HSV 1 infections where
restriction endonucleases can detect a substantial number of major
genomic variations, that enable epidemiological distinction to be
made between unrelated isolates. However, with HSV 2 infections,
specific epidemiology by RE analysis is much more difficult due to
the stability of the HSV 2 genome (see Section 2 Results). By use
of multicut endonucleases, analysis of the genome is increased but
is accompanied by an increase in the number of minor heterogeneities
due to amplification or reduction of the tandemly repeated sequences
(Roizman and Tognon, 1982; Roizman and Tognon, 1983; Hayward _et
al., 1984). In these instances a published genomic map is essential
in order to identify the hypervariable fragments and to eliminate
the possible misinterpretation of simple mobility differences as
major variations. Further verification by nick translation and
hybridisation experiments is frequently required particularly in the
identification of specific hypervariable fragments (Chaney et al .,
1983a).
The results of this study and a similar study of CMV by
Handsfield et_ a_l_. (1985) highlight the need for caution in the
interpretation of RE profiles. Isolates from known sexual consorts
involved in a stable sexual relationship may exhibit minor
heterogeneities (Fig 33) to such an extent that epidemiological
tracing may prove to be extremely difficult (Fig 34). It is, of
course, to be expected that some sexual partners attending sexually
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transmitted disease clinics will be infected with a different viral
strain, but without detailed clinical and serological data the
source of infection cannot fully be ascertained (Tables 13, 16, 17,
18) (Handsfi el d et a_l_., 1985; Rooney _et a_l_., 1986). However, if
serological and clinical data are known to be reliable then one
cannot rule out the possibility that minor mutations may occur after
transmission to a new host (Table 19). This has previously been
demonstrated in animal viruses after in vivo passage of non-plaque
purified strains (Mengel ing et a_l_., 1983; Wathen and Pirtle, 1984).
IV Oro-genital HSV
An increase in the rate of oro-genital contact among the
homosexual and heterosexual populations is well documented and has
been accompanied by a rise in the isolation of genital HSV 1 (Chacko
et a 1 ., 1982; Corey et_aj_., 1983; Soendjojo, 1983). To date very
few cases of oral HSV 2 infections have been reported (Kaufman and
Rawls, 1972 ; Nahmias and Roizman, 1973 ; Wolonitis and
Jeansson, 1977 ; Corey _et aJL, 1983 giving rise to the
suggestion that previous oral infection with HSV 1, or prior genital
infection with HSV 2, may protect against an initial HSV 2 infection
of the oral cavity (Corey et aj_., 1983; Docherty et aj_., 1984). In
support of this theory is the fact that the majority of oral HSV 2
cases documented have been primary in nature (Corey et a_l_., 1983).
The results of this Edinburgh study differ significantly from
those of other authors in that 5 HSV 1 and 5 HSV 2 oral and genital
isolations were obtained from 10 male patients. As no isolations
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were obtained from female patients it may indicate differences in
sexual behaviour or simply be a reflection of the population
sampled.
All HSV 1 specimens were isolated from primary infections of
male heterosexual patients. The HSV 2 specimens were isolated from
3 heterosexual and 2 homosexual males having primary or intial
serology with one exception (P5612, Table 22). In this instance the
patient (P5612) was found to have had antibody to HSV 2 one year
previously, although it is not certain whether this was a first
infection of the oral region. Despite this, it would appear that
prior infection with HSV did not offer protection against the
development of oral HSV 2 for this patient (P5612). All 10 patients
in this study had clinical signs and symptoms of herpetic infection,
as did the patients examined by other authors (Corey et_a_l_., 1983;
Docherty et_ a_l_., 1985). However, there is increasing evidence to
suggest that asymptomatic transmission of HSV can occur (Mertz et
a 1 ., 1985; Embil et_ aj_., 1986). This is certainly the case in
Neisseria gonorrhoea (Weisner et aj_., 1973; Young and Bain, 1983),
and Chlamydia trachomatis (Goldmeir and Darougar, 1977; Schachter,
1978) isolated from the pharynx, although it has been suggested that
the pharyngeal mucosa is not as suited to colonisation as the
urethra or cervix (McMillan et aj_., 1981).
One further theory relating to the lack of oral HSV 2 infection
is the presence of saliva. It has been reported that saliva
contains not only bacteriocidal factors but also a substance which
reduces the susceptibility of the cells to infection by HSV 1
(Heineman and Greenburg, 1980; Ross and Reith, 1985). If the
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inhibitory factors have the ability to block or limit the infection
of the oral mucosa this would explain the detection of HSV in the
saliva of patients who had no active lesions (Douglas and Couch,
1970). Similarly, if the process of blocking is specific or more
effective for HSV 2 than HSV 1 then this would account for the lack
of HSV 2 in the oral cavity.
In light of these theories REA was employed to examine the
variations between HSV isolated from oral and genital regions. As
with the larger study of genital isolates the REA was able to 'pair'
all the HSV 1 oral isolates with that of their respective genital
isolate. However, the lack of variation in the HSV 2 enabled only
four HSV 2 isolates to be paired with confidence (Table 24). Of
greater importance, perhaps, with regard to the apparent lack of
oral HSV 2, was the comparison of oro-genital HSV 1 and HSV 2
isolates with those from the genitalia (Tables 25a and b). Only one
major difference was observed between the HSV 1 oro-genital isolates
since KpnI m (1.8/1.1) was absent in the oro-genital specimens.
However, the HSV 2 isolates showed considerable variations between
the genital and oro-genital specimens, particularly in the frequency
of EcoRI f-j and BamHI w (1/1) sites. It would therefore appear
that HSV 2 isolated from concurrent oral and genital lesions differs
from purely genital HSV 2 isolates in the variability of the most
common RE sites. However, caution is needed in the interpretation of
this small number of results. A larger sample would therefore be
required before any firm conclusions can be made.
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V HSV isolations from patients in London
The results of three large scale studies of Canadian, Japanese
and Kenyan isolates have confirmed that the frequency of RE
variations in HSV differs with geographical location (Chaney et al
1983b; Sakaoka e^t 1985 and 1986). Although small in number,
only 15, the specimens from London provided an opportunity to
examine HSV isolates that were geographically distinct from those of
the Edinburgh area. All HSV 2 specimens were isolated from the
genital region whereas the HSV 1 specimens were non-genital
isolations. Within the group of HSV 1 specimens were isolates from
4 nurses (B13-16) and two patients who may have been implicated in a
possible hospital outbreak of HSV.
As in previous studies (Buchman et al., 1980; Halperin et al.,
1980) the RE data established that three isolates (B16, 17, 18) had
identical RE profiles (Table 26, Figure 36), thereby confirming the
suspected nosocomial outbreak in the intensive care unit. The
remaining six isolates (3 from the intensive care unit and 3 random
isolates) had unique RE profiles and therefore the patients were not
infected with the same HSV 1 strain as B16, 17, 18.
The HSV 2 genital isolates displayed no unusual RE variations
with only two variable sites found (EcoRI f-j and Kpnl d-i) (Table
27). This lack of variability made it impossible for
epidemiological distinctions to be made between five of the six HSV
2 isolates. Comparison of the most variable RE sites found in the
London and Edinburgh isolates revealed considerable differences
(Table 28a and b).
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Four major sites (BamHI a (5.8/2.2), d-h, w-j', and KpnI m
(2.6/0.4)) were absent in the HSV 1 (non-genital) London isolates,
and this may be a reflection of geographical variation (Table 28a),
although it is more likely that this simply reflects the small
number of isolates sampled. However, if the results are compared to
the five HSV 1 oro-genital isolates (Table 25a) it is still apparent
that their is variability in the number and frequency of the RE
sites. The London non-genital and Edinburgh non-genital (RTR)
isolates are compared in the next section. The HSV 2 genital
isolates from both London and Edinburgh again displayed frequency
variations in the most common RE sites. However, since the number
of isolates from London was very small, the results of the RE site
distributions cannot be used to establish geographical variations.
VI HSV isolations from renal transplant recipients
Herpes simplex virus is commonly isolated from transplant
patients immediately after transplant when the patients are
receiving immunosuppressive drug therapy. Previous serological
studies (Warrel 1 e_t aj_., 1980; Wal ker e_t aj_., 1982) have
established that the majority of HSV infections after transplant are
caused by reactivations of a latent virus. However, it has been
established that reinfection with a different HSV strain may occur
either from the transplanted organ (Bergl i n _et aj_., 1982) or by
other means (Mai11 and et_ a_l_., 1982; Kit et_aj_., 1983; Lewis et
al., 1984).
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The present study of renal transplant recipients revealed that
HSV was isolated from 54% of the patients after transplant. This is
in agreement with the incidence of HSV infection reported in
previous studies (Warrel 1 et_aj_., 1980 (47%); Wal ker _et a_l_., 1982
(52%)) but differs slightly from the results of Ho et al. (1983) who
reported only 40.4% infection. Consideration of the clinical
details of the patients from whom HSV was isolated revealed that 56%
were treated with cycl ospori ne/predni sol one (CsA/P) and the
remaining 44% received azothioprine/predni sol one (A/P). This
differs from other studies of renal transplant recipients receiving
the same drug therapy.
In 1983 Ho _et reported that 40% of the RTR's from whom HSV
had been isolated, were treated with CaA/P whereas 53% received A/P
therapy. More recent studies by Harri s _et a_l_. (1985) and Najarian
et aj_. (1985) have indicated that CsA/P therapy was administered to
21% and 85% (respectively) of transplant recipients with HSV
infections. These differences may be due to the sample population
and drug dosage. However, from the present study it would appear
that those patients receiving CsA/P after renal transplantation
usually developed HSV within a shorter time period than those who
were treated with the conventional azothioprine/ prednisolone
therapy (Figure 37).
During the course of the study three important applications of
REA were examined. The first involved the possible transmission of
HSV from patient LL to patients EMcI and DC (Figure 38) during
treatment in an open ward. However, no evidence of transmission of
HSV was apparent since all three individuals had unique HSV 1 RE
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profiles. The second was that the kidney itself can be a source of
viral infection as previously reported both for CMV (Weirtheim et
a 1 1983; Grundy j?t aj_., 1986) and HSV (Bergl in et_ a_l_., 1982). In
this instance, the donor was known to have had antibody to HSV
although no virus sample was available for examination. In
addition, no pre-transpl ant serology was available for one of the
two recipients.
Restriction endonuclease analysis of the isolates from both
recipients (VS and DL) revealed that the kidney could not be the
source of infection in both cases (Figure 41). Since patient DL had
antibody prior to transplant, it is most likely that the infection
was due to reactivation of a latent virus.
The final aspect was the examination of sequential HSV 1
isolates from three patients who shed virus over periods of 6 weeks
to 6 months (Figure 42). For two of the three patients, although
they differed between patients, the major RE profiles were constant
for sequential isolates. However, mobility differences were noted
particularly in fragments occurring at the junction and termini of
the genome. The remaining patient IG demonstrated a major variation
in the KpnI m (2.6/1.1) site of one isolate. In this case the
patient may have been infected with another strain of HSV 1 and
therefore had two separate HSV infections during the period sampled.
This has previously been reported for both type 1 and type 2 HSV
infections by several authors (Maitland et a_l_., 1982; Kit et al.,
1983; Lewis j2t a_l_., 1984) and in previous sections (Sections 4 and
5 of the Results).
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A direct comparison between HSV 1 isolates from different
anatomical sites, but a single geographical location (Table 30) can
be made by examining the distribution of variable RE sites found in
the HSV DNA from renal transplant recipients and those of genital
isolates. Several sites demonstrated very similar frequencies (e.g.
BamHI a (5.2/2.2), BamHI d-h, KpnI m (2.8/1.1), however KpnI m
(2.6/0.4) appeared to occur more often in (non-genital) oral HSV
isolations than in the genital HSV 1 samples. Although the
differences in frequency distribution may simply reflect the small
number of non-genital (RTR) patients sampled.
Consideration of Tables 28 and 30 shows that the 16 non-genital
isolates from Edinburgh and the seven non-genital isolates from
London vary considerably in the frequency of variable RE sites. The
London isolates lack BamHI a (5.8/2.2), w-j1 and Kpn I m (2.6/0.4)
sites and show similarity in the frequency of only one site, BamHI
d-h. Obviously, no conclusions can be drawn from this comparison
due to the small number sampled. It should be noted that other
authors (Chaney _et 1983b) have compared very small numbers of
isolates both for anatomical and geographical distribution.
Although Chaney et aJL (1983b) examined the anatomical RE variation
in 19 ganglion, 12 genital, 28 facial and 25 encephalitis isolates
each group contained a mixture of isolates from geographically
distinct areas including Canada, Japan, Britain and the USA.
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Summary
(1) Restriction endonuclease analysis of HSV DNA is a useful and
reliable means of typing virus isolates. However, for the
subtyping of virus isolates caution is needed in the
interpretation of the results, particularly when multicut
endonucleases are used.
(2) In epidemiological studies any major RE variations should be
considered since the use of mobility differences to determine
epidemiological relatedness can be misleading. To avoid
confusion, analysis should be carried out only with enzymes for
which published genomic maps are available.
(3) The variability of the HSV 1 genome and the number of genomic
maps available for multicut endonucleases allows
epidemiological tracing of HSV 1 isolates. However, analysis
of HSV 2 isolates is much more difficult due to the stability
of the genome and the lack of published genomic maps. In these
instances, where very few major variations are established, it
is of particular importance to consider the RE results in light
of full clinical and serological status.
3. Polyacrylamide Gel Electrophoresis (PAGE)
Polyacrylamide gel electrophoresis combined with a silver stain
was used to examine small molecular weight variations in HSV DNA
that could not easily be detected by agarose gel electrophoresis.
In the past, several authors have used PAGE to study DNA profiles
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for example in 1973, A11ett et al. detected lambdoid DNA fragments
by PAGE using a methylene blue stain. Using a similar technique
Favre et a]_. (1977) studied HPV DNA isolated from large quantities
of plantar warts. More recently Chaney _et aj_. (1983a) and Lewis et
al. (1984) included PAGE in their analysis of HSV isolates; however
neither author reported the type of strain used or the results of
the PAGE gels.
The technique used in the present study was ultrasensitive and
able to detect small amounts of DNA (— log). The reproducibility
of the technique and limit of detection are in agreement with the
results of Herring et aj_. (1982) for rotavirus RNA. Good resolution
was achieved with the PAGE gels (Figs 44-47) and thus small
molecular weight fragments of 2-0.5kbp could be examined in detail
after digestion with multicut endonucleases. In some instances the
silver stain detected trace amounts of cellular DNA that was not
detected by ethidium bromide staining of agarose gels (Figs 44-47).
This may demonstrate that the purification procedure of Walboomers
and/_Shegget (1976) does not necessarily eliminate all cellular DNA
from an HSV preparation. Although trace amounts of contamination
are not detected by ethidium bromide stained agarose gels, cellular
contamination may affect the clarity of the results of hybridisation
experiments.
Examination of high molecular weight fragments (15Kb-6Kb) was
not possible using the PAGE techniques if the smaller molecular
weight fragments (4-0.3Kb) were to be analysed. However, these high
molecularweight fragments were easily identified by agarose gel
electrophoresis.
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In order to overcome the difficulties in identifying variable
regions in the genome when using PAGE, standard strain DNA was
examined and variable fragments recorded. This coupled with a
molecular weight marker allowed the identification of variations
likely to be caused by junction or terminal fragments of the genome.
These regions were observed to vary both in the number and mobility
of fragments in epidemiol ogi cal 1 y related isolates (Fig 44).
However, a number of mobility differences were noted between
sequential HSV 1 isolates (from RTR's Fig 44, tracks GH and IJ) that
could neither be attributed to terminal nor junction fragments.
This observation illustrates the need for caution in using mobility
as a means of determining epidemiological relatedness.
4. Non-radiolabel1ed Detection Systems
In recent years DNA probes have provided a useful tool for
virological diagnosis as they not only allow analysis from crude
sample preparations but also offer a high degree of specificity.
Standard detection methods using radioisotopes for dot blot,
Southern or _i_n situ hybridisation have a number of limitations
associated with the problems of safety, stability, storage and
disposal of radioisotopes. However, the development of a non¬
radioactive 1 abel1 ing technique with the vitamin biotin has overcome
these problems and has proved to be much more stable than previous
methods of preparing non-radi ol abel 1 ed probes (Miller et aj_., 1966;
Renz, 1983; Renz and Kurtz, 1984; Tchen et al., 1984).
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The original objective to compare the sensitivity and
specificity of biotin with photobiotin-1 abel 1 ed DNA probes could not
be carried out due to the detection problems encountered with the
BRL-biotin kit. Precipitation of the dye solution produced
background coloration and prevented the detection of small amounts
of DNA. As this occurred both with the manufacturer's biotin
labelled sample and with DNA labelled in the laboratory the fault
was not due to the nick translation procedure. Filtration of al 1
the solutions and omission of dextran sulphate from the
hybridisation mixture did not solve the problem of dye
precipitation. Subsequent batches of dye provided by the
manufacturer produced slightly better results, however dye
precipitation continued. The dye NBT is known to be quite insoluble
and has been reported to cause difficulties in detection procedures
(Leary et_ a_l_., 1983). On further consultation with the
manufacturers it was revealed that other laboratories were
experiencing similar problems with dye precipitation. The problem
was therefore due either to production or storage of the dye
solution by the manufacturer. In any event the biotin detection kit
has recently been 'improved' to include a new 'bio-blue gene'
detection system.
Investigation of the procedure involving photobiotin used the
same NBT dyes as required for the BRL-Biotin KIT but revealed no
problems with dye precipitation or visualisation on nitrocellulose.
The probe preparation was simple and extremely quick in comparison
to the BRL system. However, the biggest advantage of the
photobiotin system was that no probe purification or visualisation
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processes were necessary to check the nick translation procedure.
Instead, the labelled DNA was coloured light orange/red dependent on
the amount of DNA present and the position of the lights used for
activation. The photobiotin-1 abel 1ed DNA probes were stable under
standard hybridisation conditions (650C) and gave reproducible
results. The BRL-biotin labelled DNA probes were only suitable for
medium stringency hybridisation (42°C) and washing procedures. This
may, in part, account for non-specific background coloration of the
ni trocel 1ul ose fi 1 ters.
Probe specificity was apparent for both biotin and photobiotin
labelled nucleic acid probes (Figs 48, 49, 50). The sensitivity of
photobiotin as determined by dot bl ot assay was good enabl ing the
detection of nanogram and picogram quantities. This is similar to
the results of Forster et aj_. (1985).
In contrast to techniques employing radiolabels photobiotin-
1 abel led probes are particularly suitable for routine application in
clinical 1 aboratories, requiring no specialised containment
facilities. Biotin/photobiotin labelled probes have the advantage
of being stable for a minimum of one year when stored at -20OC,
therefore would be ideal for a diagnostic probe especially for
viruses such as HBV and HPV that cannot be grown in cell culture.
The application of non-radi ol abel 1ed probe technology will in the
future provide both a safe and reliable method of monitoring
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The physical maps of the HSV 1 and HSV 2 genomes.
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The HSV 1 maps are shown above whereas those of HSV 2 are shown
below and are taken from published data (Cortini and Wilkie, 1978;
Wil kie et aj_., 1978; Davison and Wilkie, 1981 and 1983).
Table A
The frequency of variations in the restriction endonuclease profiles
of genital HSV 2 (DNA) found by Maitland et a_l_. (1982) and Chaney et










PPPP (0.11) 0.17 0.08
xppp (0.07) 0 0.03
xpxx (0.23) 0.13 0
xppx (0.31) 0.43 0.47
pxpx (0 ) 0 0
pppx (0.35) 0.23 0.42
ppxx (0.08) 0.03 0
xxpx (0.02) 0 0
pxpp (0 ) 0.03 0
* The values in the table are x/n where x is the number of isolates
having the variable site, and n is the total number of isolates
in the group.
a The order of digestion and abbreviations are as in Table 9a.
Table B
The frequency of variable RE sites in genital HSV 2 isolates as











EcoRI f-j 0.56 0.5 0.45
Kpnl d-i 0.83 0.89 0.81
BamHI w (1/1) ND 0.53 0.44
* The values in the tables are x/n where x is the number of
isolates having the variable site, and n is the total number of
isolates in the group.
ND - not determined.
Table C
The frequency of the most variable RE sites in HSV 1 isolates as
determined by Chaney et al. (1983b).
Chaney et al_. Chaney et^ al_
Genital Facial





b (6.2/1.8) 1 1
9 (5.2/1.8) 1 1
z-d 0.16 0.14
m (2.6/0.4) 0.58 0.25





a (7.2/0.8) 0.66 0.69
a (5.8/2.2) 0.16 0.07
Table D
Restriction endonuclease data for HSV 1 (DNA) isolated from renal
transplant recipients
Patient EcoRI Bglll HindIII Kpnl BamHI
JR P P o-h s-d
ml
a2
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al






























Patient EcoRI Bglll Hindlll Kpnl BamHI
MC P P P s-d al
b
g




AC P P m-n s-d al
g
b
WS h-k P P s-d al
g
b












Abbreviations are as in Table 8.
Abbreviations used in clinical and restriction enzyme data












VESFLU - Vesicle fluid
NS - Not specified
Restriction Endonuclease Sites
HSV 2 HSV 1
EcoRI EP - prototype ERP - prototype
EA - f-j 1 h-k
2 - k (2/1.5)


























Abbreviations used in clinical and restriction enzyme data
of HSV (1 and 2) isolates (continued)
HSV 2 HSV 1
Kpnl
BamHI
KP - prototype KPP - s-d
A - d-i 1 b (6.2/1.8)
B - m (3.1/0.9) 2 - g (5.2/1.8)
3 - m (2.6/0.4)
4 - m (1.8/1.1)
5 - p-v
BP - prototype BHP 1 (1.7/1.8)
A - w (1/1) 1 - a (7.2/0.8)





7 - o (2.4/0.2)
8 - m (2.8/0.4)
Clinical and Restriction Enzyme Data of HSV2 (DNA) Isolates
NUM3ER PATNO SITE SEX AGE DATE EP EA EB BGP BGA BGB HP HAHBHCKPKA KB KC BP BA B8 BC BD
4 M3437 CORSUL M 31 06/14/83 + + + + +
13 PI084 PREP M 33 06/15/83 + + + + +
28 P6279 CORSUL M 39 06/16/83 + + + + +
30 E4557 VULVA F 25 06/16/83 + + + + +
40 A7920 PENIS M 25 11/25/82 + + + + +
121 D3953 FRCT F 22 12/29/82 + + + + +
131 E4577 NS F 22 06/21/83 + + + + +
153 P5113 PREP M 27 11/30/82 + + + + +
154 P5112 URETH M 31 11/30/82 + + + + +
229 M7894 ANUS M 26 06/23/83 + + + + +
259 M8123 ANUS M 27 12/03/82 + + + +
316 E3821 VULVA F 26 12/06/82 + + + + +
479 P5202 PENIS M 25 12/13/82 + + + + +
524 P4493 CORSUL M 29 12/15/82 + + + + +
669 D1707 LABIA F 27 07/11/83 + + + + +
678 P5235 PREP M 23 12/18/82 + + + + +
728 E3889 VULVA F 31 12/23/82 + + + + +
732 E1405 LABIA F 41 12/23/82 + + + +
792 M3634 FRENAL M 31 12/29/82 + + + + +
830 E3203 VULVA F 21 12/30/82 t + + + +
832 E3349 CLIT F 30 12/31/82 + + + + +
858 P6445 PREP M 27 07/14/83 + + + + +
888 P5302 PREP M 30 01/04/83 + + + + +
906 E4666 LABIA F 18 07/14/83 + + + + +
908 P6297 PREP M 19 07/18/83 + + + + / +
909 K2685 PREP M 31 07/18/83 + + + + +
933 E3911 LABIA F 24 01/06/83 + + + + +
941 P1684 PREP M 40 01/06/83 + + + + +
952 E4682 FRCT F 33 07/20/83 + + + + +
955 P6476 PREP M 30 07/20/83 + + + + +
999 E905 LABIA F 31 01/10/83 + + + + +
1020 P3268 ANUS M 28 01/10/83 + + + + +
1021 P3585 ANUS M 32 01/10/83 + + + + +
1088 P4920 PREP M 21 01/13/83 + + + + +
1245 E3964 NS F 24 01/19/83 + + + •V +
1294 A8364F NS F 26 01/20/82 + + + + +
1367 P5428 CORSUL M 18 01/24/83 + + + + +
1388 06980 INTR F 32 01/25/83 + + + + +
1446 P5455 PREP M 31 01/27/83 + + + + +
1654 D6402 LABIA F 35 02/03/83 + + + + +
1662 A8341F CX F 22 02/04/83 + + + + +
1701 E4046 VULVA F 19 02/04/83 t + + + +
2033 E4105 VULVA F 19 02/17/83 + + + + +
2094 E4116 VULVA F 26 02/21/83 + + + +
2129 M9269 VESFLU M 21 02/22/83 + + + + +
2135 A8412 NS M 24 02/23/83 + + + + +
2187 E3697 LABIA F 22 02/24/82 + + + + +
2573 MXARC NS F 22 03/10/82 + + + + +
Clinical and Restriction Enzyme Data of HSV2 (DNA) Isolates (cont)
NUNBER PATNO SITE SEX AGE DATE EP EA EB BGP BGA BG8 HPHAHBHCKPKAKBKCBPBAB8BCB0
2574 HALL IK NS F 17 03/10/83 + + + + +
2599 E4179 CX F 21 03/10/83 + + + + +
2604 P5687 ANUS M 31 03/11/83 + + + + +
2643 P5178 GLANS M 30 03/14/83 + + + + +
2662 P5718 PENIS M 21 03/15/83 + + + + +
2710 P5721 PREP M 19 03/15/83 + + + +
2843 P3000 CCRSUL M 34 03/18/83 + + + + +
2884 P1274 PENIS M 20 06/01/81 + + + + +
3082 E4250 CX F 29 03/30/83 + + + + +
3097 D4189 ANUS F 26 07/01/83 + + + +
3251 P5837 URETH M 25 04/05/83 + + + + +
3361 E4284 LABIA F 36 04/11/83 + + + + +
3528 FIRTHS VESFLU M 21 04/15/83 + + + + +
3561 M9185 PENIS M 33 06/25/81 + + + + +
3621 K4891 PREP M 47 04/20/83 + + + + +
3700 A8523 NS M 21 04/22/83 + + + + +
3770 E4345 1NTR F 37 04/27/83 + + + + +
3828 M6518 URETH M 31 04/29/83 + + + + &
3862 P5988 URETH M 45 05/03/83 + + + + +
4168 A8536 NS M 23 05/12/83 + + + + +
4169 P4384 URETH M 28 05/12/83 + + + + +
4216 E4402 VULVA F 23 05/12/83 + + + + +
4238 E4323 VULVA F 26 05/13/83 + + + + +
4305 E4427 CX F 22 05/17/83 + + + + +
4360 E4432 CX F 21 05/18/83 + + + + +
4826 P5830 PREP M 26 06/08/83 + + + + +
5950 E5424 VULVA F 22 02/01/84 + + + + +
6010 P7732 CCRSUL M 57 02/02/84 + + + + +
6060 P4280 PREP M 22 10/18/82 + + + + +
6097 M9838 PREP M 24 10/19/82 + + + + +
6226 M7069 GLANS M 26 10/25/82 + + + + +
6263 P4867 URETH M 49 10/26/82 + + + + +
6443 P4911 FREN M 31 11/03/82 + + + +
6593 E3234 VULVA F 22 02/21/84 + + + + +
6670 D9692 CX F 21 11/11/82 + + + + +
6675 E3719 CX F 20 11/11/82 + + + + +
6744 P4995 PENIS M 43 11/12/82 + + + +
6801 E3737 CX F 30 11/15/82 + + + + +
6890 KERRAK NS M 25 11/19/82 + + + + +
7098 M6180 PENIS M 35 03/09/84 + + + + +
7358 M5833 ANUS M 34 03/19/84 + + + + +
8155 P2900 PREP M 24 01/06/82 + + + + +
8163 M5359 URETH M 21 01/07/82 + + + +
8209 P2914 PREP M 27 01/08/82 + + + + +
8370 E2427 CLIT F 36 01/13/82 + + + + +
8386 D578 LABIA F 47 01/15/82 + + + + +
8501 P2962 PREP M 20 01/19/82 + + + + +
8545 E2429 CX F 19 01/21/82 + + + + +
Clinical and Restriction Enzyme Data of HSV2 (DMA) Isolates (cont)
NUMBER PATNO SITE SEX AGE DATE EP EA EB BGP BGA BG8 HP HA HB HCKPKAKBKCBPBABB BC BD
8556 K9224 PREP M 25 01/21/82 + + + + +
8748 M3483 PREP M 22 01/28/82 + + + +
8751 E2482 VULVA F 21 01/28/82 + + + + +
8762 K9349 PREP M 30 01/28/82 + + + + +
8883 P2346 FREN M 29 02/03/82 + + + + +
8913 P3053 NS M 31 02/04/83 + + + + +
9049 M6890 PENIS M 23 05/29/79 + + + + + +
9056 D2181 NS F 33 01/10/82 + + + + +
9091 P3097 PENIS M 24 02/11/82 t + + + +
9156 D3612 LABIA F 25 02/15/82 + + + + +
9221 E5523 VULVA F 24 05/25/84 + + + + + *
9251 P1836 PREP M 43 02/16/82 + + + + 1
9252 El088 a F 34 02/16/82 + + + + +
9301 08859 LABIA F 34 02/18/82 + + + + +
9417 H3996 PREP M 41 02/23/82 + + + +
'
+
9616 P2864 PREP M 46 03/02/82 + + + + +
9639 P3238 PENIS M 29 03/04/82 + + + +
9707 M357 PENIS M 35 03/05/82 + + + + +
9846 D9322 INT F 28 03/12/82 + + + + +
10057 E2692 INT F 29 03/22/82 + + + + +
10079 P3374 URETH M 34 03/23/82 + + + + +
10137 E2289 LABIA F 33 03/23/82 + + + + +
10597 P3498 PENIS M 35 04/12/82 + + + + +
10603 P3501 PREP M 32 04/13/82 + + + + +
10713 P3518 VESFLU M 38 04/16/82 + + + + +
10811 E2826 NS F 32 04/22/82 + + + + +
11008 D6523 LABIA F 26 04/30/82 + + + + +
11011 D9369 ANUS F 34 04/30/82 + + + + +
11071 E2697 cx F 19 05/05/82 + + + + + •v
11073 PI370 PREP M 23 01/27/82 + + + +
11249 M8943 PENIS M 22 08/03/84 + + + + +
11253 P3667 CCRSUL M 24 05/12/82 + + + + +
11255 P3670 C0RSUL M 21 05/12/82 t + + + +
11256 P4132 NS M 25 06/15/83 + + + + +
11268 P8863 PENIS M 27 08/06/84 + + + + +
11313 E2832 INTR F 21 05/14/82 + + + + +
11331 E2914 VULVA F 19 05/17/82 + + + + +
11356 P3699 PREP M 27 05/18/82 + + + + +
11517 E2940 CX F 14 05/24/82 + + + + +
11628 P3356 CCRSUL M 72 05/27/82 + + + + +
11640 E2653 NS F 33 05/28/82 + + + + +
11709 E2971 LABIA F 32 05/29/82 + + + + +
11887 M2267 PREP M 37 06/08/82 + + + + +
11954 P3860 PREP M 41 06/10/82 + + + + +
11984 E3020 CX F 19 06/11/82 + + + + Hr
12472 P3977 PREP M 31 07/01/82 + + + + +
12473 El547 NS F 22 07/11/82 + + + + +
12492 E3118 VULVA F 20 07/02/82 + + + + +
Clinical and Restriction Enzyme Data of HSV2 (DNA) Isolates (cont)
NUNBER PATOO SITE SEX AGE DATE EP EA EB BGPBGABGB HP HA HB HCKP KA KB KC BP BA BB BC BD
12494 E3114 FRCT F 19 07/02/82 + + + + +
12574 P3995 GLANS M 18 07/05/82 + + + + +
12641 E3137 INT F 21 07/07/82 + + + + +
12661 P4030 PREP M 26 07/08/82 + + + + +
12734 P4052 PREP M 27 07/12/82 + + + + +
12746 P4058 GLANS M 25 07/12/82 + + + + +
12753 EMM PERINM F 21 07/13/82 + + + + +
12756 P4063 PREP M 30 07/13/82 + + + + ¥
12790 E3166 ANUS F 21 07/14/82 + + + + +
12813 E3171 VULVA F 23 07/15/82 + + + + +
12832 A8041 NS M 43 07/15/82 + + + + 4
12928 P4124 PENIS M 52 07/21/82 + + + + 4
12929 M7847 PENIS M 21 07/21/82 + + + + +
12993 P4147 PREP M 23 04/23/82 + + + + +
12995 P4144 CCRSUL M 21 07/23/82 + + + +
4
13078 El574 FRCT F 19 07/27/82 + + + + +
13111 A7737F NS F 21 07/28/82 + + + + +
13140 P4177 GLANS M 25 07/29/82 + + + + +
13141 E3215 LABIA F 19 07/29/82 + + + + +
13190 D9353 CX F 23 07/30/82 + + + + +
13226 P4204 PREP M 33 08/03/82 + + + + 4
13307 M6693 PREP M 30 08/05/82 + + + + t
13311 P4218 PREP M 35 08/04/82 + + + + +
13364 P2231 AMIS M 24 08/06/82 + + + + +
13365 D5419 CX F 27 08/09/82 + + + + 4
13367 H8232 PENIS M 32 02/14/80 4 + + + +
13369 E3262 CX F 31 08/09/82 + + + + +
13398 P4259 C0RSUL M 22 08/10/82 + + + + 4
13398 P4259 C0RSUL M 22 08/10/82 + + + +
13403 E3279 CX F 23 08/10/82 + + + + +
13468 E3284 LABIA F 24 08/12/82 + + + + +
13470 D3031 CX F 30 08/16/82 + + + + +
13824 E2281 LABIA F 23 08/31/82 + + + + +
13826 P2825 BUTT M 34 08/31/82 + + + + 4
13851 D4314 CX F 23 09/01/82 + + + + +
13871 P4446 PREP M 30 09/02/82 + + + + +
13936 P95 PENIS M 35 09/03/82 + + + + 4
13941 P4339 THIGH M 34 09/04/82 + + + + +
13993 P4484 PENIS M 29 09/07/82 + + + + +
13996 E3406 CLITOR F 19 09/07/82 + + + + +
14027 P3699 NS M 38 09/07/82 + + + + +
14222 K9835 PREP M 34 09/15/82 + + + + +
14302 D473 LABIA F 42 09/22/82 + + + + +
14357 P4608 PENIS M 24 09/23/82 + + + + 4
14557 P4604 NS M 22 10/01/82 + + + + +
14633 E1748 INTR F 20 10/05/82 + + + + +
14927 E3577 CX F 26 10/14/82 + + + + 4
14992 P3740 PREP M 33 10/15/82 + + + + -4
15900 P9948 PENIS M 22 01/16/85 + + + + +
16092 P9968 ANUS M 26 01/18/85 + + + + +












Clinical and Ftestricficn Enzyme Certa of HSV1 (CNA) Isolates
F83 PA7N0 SITE SEX K3L DATE EFP ER1 BR2 ER3 534 Bg3 B31 5G2 HP H31 K32 H33 KD4 K35 l<FP hPI YPZ t«P3 KF4 KP5 B-P EH1 EH2 EH5 EB1 EK5 EH5 EH7 SHg
29 e4553 vulva f 21 06/16/83 + + + + + + + + + 4 -
88 e4566 cx f 23 06/17/83 + + + + + +
231 f5338 fb1ism 28 06/24/83 + + + + + + + + +
318 e3324 vulva f 18 12/07/82 + + + + + + ■v +
374 e3832 fefn f 23 12/09/82 + + 4 + + + + +
609 e3333 vulva f 29 12/17/82 + + + + + + + + +
873 p5454 wjs m 25 07/15/83 + - + + + + + + +
951 ds830 ns f 23 05/03/81 4 + + + +
1085 0937 la3ia f 23 01/12/83 + + + + + + +
1383 0562 cx f 21 01/24/83 + + + + . • 'J. 4- +
1403 m1693 f94is m 30 03/22/77 + + + + + + + +
1420 0936 l/biaf 32 01/25/^5 + 4 + + + + + + +
1728 e4057 vulva f 22 01/24/83 + + + + + + + + +
1827 mX)F ns f 20 02/10/83 + + + + + + + +
1940 e4088 vulva f 22 02/15/83 + + + + + + +
2337 ^6410f ns f 21 02/17/83 + + + + -¥ + +
2776 e4199 vulva f 18 03/17/33 + + + + + +
3079 e3227 vulva f 23 03/31/83 + + +• . + + + + ' +
3349 ia8837 fbmsm 16 10/14/83 + + +
'
+ + + + +
3303 e4347 cx f 23 04/28/83 + + + + + + + ' +
4022 pi752 fb3t m 3d 07/13/81 + + + + + + + +
4083 r5032 fe^ls m 32 05/04/83 + + + + + + + +
4287 e4417 vulva f 22 05/16/83 + + + + + + + +
4547 e4479 int f 2d 05/77/83 + + + + +
4552 e4476 vulva f 19 05/z7/83 + + + + + + +
4639 m3493 fbjis m 21 05/25/78 + + + + + + +
3328 e5309 l/6ia f 23 03/11/82 + + + + + + +
6075 e1492 cx f 21 10/19/82 + + + + + + + +
6446 p7829 pb^is m 23 02/16/84 + + + + + + + +
6509 e3695 vulva f 19 11/05/82 + + + + + + +
6517 0682 vulva f 19 11/05/82 + + + + + + 4
6608 e37c6 cx f 18 11/08/82 + + + + + +
7899 e5303 vulva f 33 06/04/84 + + + + + + + + +
8039 p2872 pbjism 18 12/33/81 + 4 + + + + +
8513 c6440 wn f 24 01/23/82 + + + + + + + +
8935 e1593 f 19 04/02/82 + + + + + + +
9058 e2531 l/biaf 37 02/10/82 + + + + + + +
9332 e2569 vulva f 21 02/18/82 + + + + + + + + +
9495 ks816 gums m 16 06/01/75 + + + + + + +
9606 e2522 l/6ia f 19 03/02/82 + 4 + + + + + -v +
10525 ez779 vulva f 19 12/07/82 + + + + + + + +
1c874 (35112 vulva f 23 04/23/32 + + + + + + + + +
11094 a7948 ns m 19 05/05/82 + + + + + + + + +
12347 ex8 fbn f 19 06/18/82 + + + + + + + + +
12094 d1800 cx f 25 06/15/82 4 + ' + + + + +
12095 p2935 lrif€m 21 06/14/82 + + + + + + + +
12201 e3365 l/bia f 29 06/21/82 + + + + + + + +
13059 e225 wjs f 20 07/26/82 + + + + + +
13257 e3251 l/biaf 25 c8/05/82 + + + + +
13578 p4322 MJS M 24 08/19/82 + + + + + + + +
13663 p379 rtus m 35 c8/25/82 + + + + + + + +
13748 c8246 ns f 23 09/02/82 + + + + + + + +
14023 p4488 ffep m 18 09/07/82 + + + + + + +
14277 e1491 vulva f 22 09/21/82 + + + + + + + \
14615 k6364 ffep m 27 10/04/82 + + + + + +
14739 e3422 an f 18 10/08/82 + + + + + + + + +
